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1 Introduction 
	
	
	
1.1 Oxygen is necessary for survival of multicellular organisms 
 
Complex organisms require oxygen (O2) for energy production. Deprivation of oxygen 
not only halts proper cell functions but also leads to free radical accumulation and 
concomitant stress on proteins and DNA. Normal levels of atmospheric oxygen are 21% and 
are referred to as normoxia. However, the partial oxygen pressure in tissues is variable and 
depends on the metabolic requirements of the specific tissue and its functional state. This 
physiological and tissue-specific partial oxygen pressure is referred to as physioxia. In 
humans this measure varies anywhere between 1 and 11% (Carreau et al. 2011). 
Specifically, early data shows partial oxygen pressure of the lung alveoli, is around 13%, and 
then significantly lower in other tissues such as kidney cortex 6%, brain 4,6%, reaching 5% in 
bone marrow (Carreau et al. 2011). Moreover, any local or global decrease in oxygen 
availability in the microenvironment is considered pathological and loosely termed as 
hypoxia. Ongoing research, including my own, aims to connect the reaction of tissue 
microenvironments to hypoxia and the subsequent cellular effects to compartments within 
this tissue.   
 Remarkably, recent data acquired with the help of live-tissue imaging showed that 
within bone, physioxia is heterogeneous and region-dependent. Bone is a diverse tissue 
consisting of four layers (Fig. 1):  
1. Periosteum – the most outer covering layer of surface bone  
2. Cortical bone – the hard and thick mineralized tissue giving the bone its structure and 
strength 
3. Cancellous bone – typically found in the end of long bones (the epiphysis) or within 
vertebrae; it is a spongy mineralized tissue assuring flexibility. It frequently contains 
bone marrow 
4. Bone marrow – located inside the marrow cavity of cortical and cancellous bones. 
This highly vascularized tissue consists of many cell types supporting blood cell 
production (hematopoiesis). 
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Figure 1 Four components of long bones. 3D reconstruction obtained by micro computing tomography of 
femur methaphysis of control male mouse. Long bones have a shaft and two ends. The outside layer called 
periosteum encloses the bone. The outer shell of most bones forms cortical bone. At the ends of long bones 
disorganized, porous cancellous tissue also known as trabecular bone surrounds marrow-containing cavities. 
Bone marrow also resides in the long shaft known as marrow cavity. Image of WT mouse femur taken with help of 
the Bone lab.  
 
Measured oxygen levels varied from 1-4% with lowest levels within the marrow cavity 
and the highest oxygen levels observed in vicinity of the cortical bone (Spencer et al. 2014). 
Studies on O2 consumption by hematopoietic cells revealed high utilization, suggesting that 
oxygen pressure decreases 10-fold within a distance of several cells starting from the 
nearest capillary (D. C. Chow et al. 2001). However, if the heterogeneity in oxygen pressure 
has a function is not yet well established. One particular known effect of low oxygen tension 
is a role in maintenance of cellular quiescence in multiple stem cell types (Suda et al. 2011). 
Additionally, oxygen tension is an important determinant of hematopoietic stem and 
progenitors cell proliferation and differentiation (Hawkins et al. 2013). Therefore the capability 
to sense an acute decrease in an environment with limiting oxygen levels likely must be 
immediate, leading to rapid adjustment of metabolism, altered gene expression and 
ultimately disruption of homeostasis.  
 
1.2 Oxygen sensing is necessary for induction of rapid cellular 
response  
 
 Most transcriptional responses to oxygen levels are mediated by two hypoxia 
inducible factors (HIF) HIF-1 and HIF-2. Under normoxic conditions both factors are 
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recognized by prolyl hydroxylase domain proteins (PHD) 1-3 isoforms (Bruick & McKnight 
2001; Epstein et al. 2001) leading to their subsequent hydroxylation (Berra et al. 2003; Bruick 
& McKnight 2001). Hydroxylated HIF is recognized by von Hippel-Lindau protein (VHL) that 
in turn recruits ubiquitin E3 ligase leading to HIF ubiquitination and consequently 
proteasome-dependent degradation (Ivan et al. 2001; Jaakkola et al. 2001). However, HIF 
levels increase dramatically and rapidly upon hypoxic conditions (Semenza et al. 1991; Ema 
et al. 1997; Jiang et al. 1996; Tian et al. 1997), suggesting an acute halt to this process. In 
absence of oxygen, PHD hydroxylase activity is inhibited (Ehrismann et al. 2007) and HIF is 
stabilized, dimerizes, and translocates into the nucleus where it activates expression meant 
to overcome hypoxic situation (Fig. 2).    
 
 
Figure 2 Overview of the hypoxia sensing pathway. In normoxic conditions PHD is active in the presence of 
oxygen. PHD hydroxylates HIF. Hydroxylated HIF is recognized by VHL ligase, ubiquitinated and subsequently 
directed for proteosomal degradation. During hypoxia, PHD is inactive, HIF is stabilized, dimerizes and 
translocates to the nucleus where it interacts with DNA and activates gene expression. 
 
HIF regulated genes regulate essential processes such as glucose metabolism 
(Semenza 2003), erythropoiesis (Semenza et al. 1991), and angiogenesis (Semenza 2003). 
Moreover, hypoxia has a key role in maintaining the undifferentiated state in different types of 
stem cells like neuronal (Mazumdar et al. 2010), mesenchymal (Méndez-Ferrer et al. 2010) 
or hematopoietic stem cells (Takubo et al. 2010). Specifically, hematopoietic stem cells 
control maintenance of quiescence under HIF-1 signaling (Singh et al. 2013).  
Hypoxic signaling in the hematopoietic cells is critical in tumor development. 
Remarkably, inhibition of tumor growth is mediated in part through HIF-1a signaling changes 
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in myeloid and cells and T lymphocytes. Loss of PHD2 in these cells resulted in expression 
changes of protumoral and antitumor genes sufficient to reduce tumor growth (Mamlouk et 
al. 2013). Interestingly, HIF-1 and HIF-2 transcription factors activate different signaling 
pathways (Franke et al. 2013). Our lab has shown that conditional knockout of PHD2 from 
hematopoietic, renal and nervous cells resulted in overexpression of erythropoietin levels 
exclusively by HIF-2, while HIF-1 induced signaling ensured survival of the mouse with 
extreme polycythemia (Franke et al. 2013). However, the signaling changes mediated by the 
hypoxia inducible transcription factors are dependent on the variation and expression levels 
of HIF genes between different cell types (Chi et al. 2006; Stenmark et al. 1999).  Questions 
regarding precise changes to tissue specific gene expression, signal transduction pathways, 
and the interactions between tissue types upon hypoxic conditions remain unanswered 
(Meneses & Wielockx 2016).  
 
1.3 Endothelial and hematopoietic tissues together deliver oxygen 
 
Vertebrates have developed two distinct tissues to assure that oxygen delivery is fast 
and efficient. A network of vessels assures rapid distribution and delivery of O2, CO2, and 
nutrients. All vessels are tightly lined with endothelial cells that allow exchange of gases and 
nutrients, and enable the transport and exchange between the periphery and tissues. To 
assure efficient delivery throughout the organism, all vertebrates evolved a specialized cell, 
the erythrocyte, whose sole function is to transport maximum molecules of O2 (Fig. 3). 
Erythrocytes, commonly called red blood cells (RBCs), belong to the hematopoietic system. 
They have maximized the oxygen transport efficiency on the expense of many common 
metabolic functions by:  
a) developing the ability to synthetize hemoglobin – respiratory pigment,  
b) changing shape, which allows efficient oxygen uptake and capacity to move rapidly 
through entire body without losing its content. 
Other hematopoietic cells include white blood cells and platelets. Functionally, blood cells 
together are responsible for: 
a) Transport – O2, CO2, nutrients, waste products, hormones.  
b) Protection – targeting of invading pathogens.  
c) Regulation – regulation of pH, water balance, and other parameters. 
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Figure 3 Schematic of components necessary for rapid and efficient delivery of oxygen to all tissues. 
Endothelial cells lining the circulatory system form a delivery network (left) of vessels to assure fast delivery. 
Efficiency is maintained by the production of specialized cells to transport maximal number of oxygen molecules 
(right) called erythrocytes. Erythrocytes have high concentrations of hemoglobin that aside of its oxygen 
transporter function is also a pigment, giving the erythrocyte very specific red color. Other hematopoietic cells that 
circulate within vessels are represented in grey. 
 
Although endothelial and hematopoietic cells are very distinct, it is believed they share a 
common embryonic progenitor – the hemangioblast (K. Choi 2002; K. Choi et al. 1998; 
Jaffredo et al. 2005). Hemangioblast is a proposed to be transient cell that loses its dual 
potential after hematopoietic and endothelial progenitors have been established (Mikkola et 
al. 2002.). However, data in literature exist that question the existence of such a progenitor 
due to the lack of success of fate mapping studies in vivo (Eichmann et al. 2002). Despite 
controversy over the embryonic progenitor, the process of adult blood production is well 
understood.  
  
1.4 Hematopoietic stem cells give rise to blood cells  
 
All classes of mature blood cells are derived from bone marrow resident 
hematopoietic stem cells (HSC) in adults, through progressive loss of differentiation 
potentials for other cell lineages. Hematopoietic stem cells are used in therapy of various 
diseases, thus it is essential that we can differentiate very rare, self renewing pluripotent cells 
from lineage committed progenitors (Morgan et al. 2017). Although the gene expression 
profiles of many stem cell populations have been described (Ivanova et al. 2002; Ramalho-
Santos et al. 2002), a single surface receptor that identifies the stem cell may not exist. Thus, 
a combination of markers is commonly used that select for cells with stem cell potential. It 
has been shown that HSCs are enriched in the population of cells lacking any mature lineage 
markers (Lin-), while expressing two surface markers – stem cell antigen-1 (Sca1) and 
tyrosine-protein kinase KIT (cKit). Cells defined by these three markers are referred to as 
LSK cells (Ikuta & Weissman 1992; Okada et al. 1991). Though, within this LSK cell 
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population, only around 20% of cells have the ability to reconstitute the entire hematopoietic 
compartment (Morrison et al. 1995).  
Advances in understanding HSC biology and development of methodologies enable 
us to further distinguish this heterogeneous population into subpopulations based on 
additional cell surface markers (Kiel et al. 2005) (Fig. 4). These fall into long term and short 
term HSCs (LT-HSCs and ST-HSCs, respectively), depending on their ability to reconstitute 
the entire hematopoietic compartment. Long-term HSCs (LT-HSC; CD150+, CD48-, LSK) 
are characterized by the capacity to fully sustain hematopoiesis after myeloablation, while 
short-term HSCs (ST-HSC; CD150-, CD48-, LSK) possess that ability only for a limited time 
(Kiel et al. 2005; Oguro et al. 2013). In adults, LT-HSC are found mostly in a quiescent state 
that protects them from DNA damage arising from numerous intrinsic and environmental 
sources and ensures their persistence (Arai et al. 2004; Cheng et al. 2000). These stem cells 
give rise to highly proliferative multipotent progenitors (MPP) that retain stem cell markers 
(e.g. LSK cells), but loose their self-renewal potency (A. Wilson et al. 2008; Oguro et al. 
2013).  
 The MPP cell population can be further divided into MPP2 (CD150+, CD48+, LSK) 
and MPP3/4 (CD150-, CD48+, LSK). These two classes of progenitors have different 
transient reconstituting capabilities, namely, MPP2 had the capacity to repopulate the 
hematopoietic cells post transplantation for a longer time period than MPP3/4 (Oguro et al. 
2013). MPPs are the final stem cell type with multipotent capability.   
	
Figure 4 Schematic of hierarchical differentiation of hematopoietic stem cells. All undifferentiated and 
progenitors with different levels of self-renewing capacity are characterized with a lack of mature lineage specific 
surface markers (Lin-), and presence of two receptors - Sca1 and cKit. The stem and progenitor cells can by 
identified by differential levels of two surface markers expression. For example, long-term hematopoietic stem 
cells (LT-HSC) exhibit high expression of CD150 and low levels of CD48. As the differentiation of the 
hematopoietic stem cell progresses, it loses the ability to self-renew. As LT-HSC differentiate into short-term 
hematopoietic stem cells (ST-HSC) it loses its high levels of CD150 receptor. ST-HSC then differentiates into 
multipotent progenitors that are defined by high levels of both CD150 and CD48. Lastly, the multipotent 
progenitors (MPP3/4) are characterized by have high levels of CD48 and loss of CD150. These cells have low 
self-renewing capability but are still pluripotent.  
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Subsequent progenitors can be characterized by lack of Sca1, a principle stem cell 
marker (N. K. Wilson et al. 2015) (Fig. 5). Moreover, their lineage commitment is restricted to 
the myeloid compartment known as common myeloid progenitors (CMP) (Pronk et al. 2007). 
Common myeloid progenitors (CMPs) can be divided into three types of progenitors: 
a) Megakaryoctyte-erythrocyte progenitors (preMegE)– bipotent progenitors giving rise 
to erythrocyte (CFUe) and platelet (MkP) progenitors 
b) Myeloid progenitors (GMP)– ultimately give rise to monocytes, neutrophils and 
granulocytes 
c) Lymphoid progenitors – give rise to B and T lymphoid cells. 
Interestingly, endothelial cells have been shown to be crucial for proliferation and 
differentiation of megakaryocytes and myeloid progenitors (Rafii et al. 1995).  To assure 
amplification in the number of differentiated mature cells, these progenitors differentiate 
further into single lineage cells precursors that maintain a highly proliferative capacity. This 
organization of progenitor differentiation leads to the overall production of 2x1011 cells per 
day over the entire life span of organism. This very dynamic system requires meticulous 
regulation and maintenance to assure proper orchestration of cell production.  
	
Figure 5 Schematic of hierarchical differentiation of stem and progenitor cells. All mature hematopoietic 
cells are derived from hematopoietic stem cells (HSC). As hematopoietic stem cells differentiate into multipotent 
progenitors (MPP), they lose their self-renewal potential. MPP can differentiate into common myeloid progenitor 
(CML) and common lymphoid progenitor (CLP). CLP through a series of transitory progenitor stages ultimately 
gives rise to all lymphoid cells. CMP is a bi-potent progenitor that gives rise to megakaryocyte/erythrocyte 
progenitor (preMegE) and granulocyte/macrophage progenitor (preGM). preGM is restricted in lineage into the 
production of myeloid leukocytes. PreMegE can further differentiate into lineage restricted megakaryocyte 
progenitor (MkP) producing platelets and erythrocyte specific colony forming unit (CFU-e) cells that ultimately give 
rise to red blood cells. 
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1.5 Regulation of HSCs is dependent on cells of the hematopoietic 
niche 
 
HSCs reside in bone marrow (BM) where a specific microenvironment called the 
niche orchestrates their activity. The niche is composed of many cell types, including the 
endothelial (EC) and hematopoietic cells I have discussed, as well as skeletal progenitor 
cells, adipocytes, stromal cells and neurons. Here, decisions about quiescence and 
proliferation are signaled by neighboring cells, extracellular matrix or soluble growth factors 
(Adams et al. 2006; A. Wilson et al. 2004). Initially, it was postulated that there were two 
functionally distinct niches within bone marrow: an endosteal (Fig. 6) – where most quiescent 
HSCs would be in proximity to osteoblasts, and the perivascular – where endothelial cells 
play a crucial role for highly proliferating progenitors (Calvi et al. 2003; Rafii et al. 1995) 
It is known that endosteal niche revolves around osteoblasts found on the interface of 
bone and marrow. Osteoblasts secrete factors and express receptors crucial for HSCs 
maintenance in quiescence such as thrombopoietin (Yoshihara et al. 2007), angiopoietin 
(Arai et al. 2004), Notch-1 (Calvi et al. 2003) and N-cadherin (Zhang et al. 2003). However, 
recent data shows that endothelial cells are equally indispensable for LT-HSCs (Butler et al. 
2010). Moreover, ECs express many of the secreting factors and receptors crucial for HSC 
quiescence regulation such as CXCL12 (Ding & Morrison 2014), SCF (Ding et al. 2012) or E-
selectin (Winkler et al. 2012). Recent advances in imaging revealed that although HSCs 
preferentially localize in the endosteal zone, a majority of them interacts with BM vasculature 
(Nombela-Arrieta et al. 2013). Moreover, sinusoidal endothelium and hematopoietic cells 
have a codependent relationship. Unlike capillaries in other organs, marrow sinusoidal 
endothelial cells (SEC) lack basal lamina, resulting in their delicate structure. Therefore, 
bone marrow SECs rely on a close association with hematopoietic cells for structural 
stability. 
HSCs closely associated to vessels are thought to be residing in perivascular niches. 
Here many cells in addition to endothelial cells surround them. Stromal cells in the vicinity of 
endothelium have major impact on the HSC activity (Chan et al. 2009; Méndez-Ferrer et al. 
2010; Morikawa et al. 2009). Additionally, other cell types such as Schwann neural cells (S. 
Yamazaki et al. 2011), CXCL12 abundant reticular (CAR) cells (Sugiyama et al. 2006) and 
adipocytes (Naveiras et al. 2009; Zhu et al. 2012) directly maintain and regulate HSCs. 
Moreover, mature hematopoietic cells such as macrophages and megakaryocytes also have 
roles in modulating the niche (Bruns et al. 2014; A. Chow et al. 2011; Christopher et al. 2011; 
Winkler et al. 2010; Zhao et al. 2014). This provides a feedback loop, whereby the mature, 
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differentiated cells directly influence their own progenitors. This heterogeneous environment 
relays the signals in various ways to assure proper functioning of the entire system. 
 
Figure 6 Model of spatially distinct hematopoietic stem cell niches. Hematopoietic stem cells (HSC) are 
thought to reside in two distinct niches – endosteal and perivascular. Endosteal niche is localized in the vicinity of 
bone. Here the most prominent cell type – the osteoblast and HSCs directly interact with each other by the 
receptor interaction or expression of cytokines. In contrast, perivascular niche refers to the cells residing in the 
vicinity of endothelial cells. Here HSCs are regulated by clues from endothelial cells, CXCL12 abundant reticular 
cells (CAR), Schwann cells, megakaryocytes, macrophages, adipocytes or sympathetic nerves.  
 
1.6 Types of HSC regulation 
 
The most obvious manner of regulation is through cell-cell contact that engages direct 
contact of membrane receptors between HSC and regulatory cells (Adams et al. 2006; 
Winkler et al. 2012). In particular, HSC need cell-cell interaction with perivascular cells - 
specifically Sl/Sld mice that express soluble but not membrane bound SCF on pericytes, 
revealed severe depletion of HSC (Barker 1994) suggesting requirement of membrane 
bound interaction (Fig. 7).  
 Another form of direct impact is by secretion of many cytokines and growth factors 
which then diffuse or are transported in the vicinity of HSC – this form of regulation does not 
require immediate contact (Ding et al. 2012; Greenbaum et al. 2013). A perfect example of 
such regulation is the activation of Notch signaling on HSC through endothelial (Poulos et al. 
2013) cell or osteoblast (Calvi et al. 2003) derived soluble Jagged-1 expression, leading to 
an increase in HSC numbers. Moreover, cells expressing angiocrine effectors do have to 
reside in the niche itself. Endothelial cells from multiple tissues, not only bone marrow, have 
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been shown to upregulate G-SCF upon bacterial exposure. G-CSF is delivered to bone 
marrow, where it acts on myeloid progenitors, increasing its activity that ultimately leads to 
accelerated neutrophil generation (Boettcher et al. 2014).  
 Lastly, another possibility for impacting HSC activity is by changing cell composing 
niche activity and therefore influencing regulation of the HSC (Schuettpelz & Link 2013) . 
Immune cells can indirectly regulate HSPCs through signaling via MSC. In particular, 
prostaglandin E2 expressed by CD169+ macrophages increases expression of CXCL12, 
angiopoietin and vascular cell adhesion molecule-1 (VCAM-1) in MSC that in turn affect HSC 
(A. Chow et al. 2011).  
	
Figure 7 Schematic of three types of HSC regulation. A complex and diverse regulation of hematopoietic stem 
cells (HSC) can be executed by direct and indirect interaction of cells residing in niche and HSC. Direct 
interaction can involve immediate cell-cell contact. As example of such interaction is CXCL12 abundant reticular 
(CAR) cells membrane bound SCF that directly regulates the maintenance of HSC. Here direct interaction of CAR 
membrane bound, but not soluble SCF with cKIT receptor on HSC membrane is necessary for proper HSC 
function (a). Similarly, HSC can be regulated directly through expression of cytokines that diffuses or is actively 
transported to the HSC (b). Lastly, cells can indirectly modulate HSC activity by influencing other cells residing in 
niche (c).  
  
Taken together, cellular and molecular interactions of HSC with cells residing in niche 
are necessary for regulation and maintenance of hematopoiesis. In cases where bone 
marrow function has been perturbed and the signaling from niche is altered due to the stress, 
hematopoiesis occurs in organs other than bone marrow, such as the spleen (Pelusi et al. 
2017; Cheshier et al. 2007; Baldridge et al. 2010; Morrison et al. 1997). Examples of 
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situations where bone marrow signaling is perturbed are irradiation, anemia, or infection. 
Irradiation is commonly used in current therapy for many cancers  
 
1.7 Cancer therapy affects all highly proliferating cells  
 
Current strategies for cancer eradication require surgery and a combination of 
chemotherapy and/or radiation therapy (NIH page). Radio and chemotherapy both target fast 
proliferating cells either by introducing double stranded breaks in DNA or by synthesis 
inhibition of components necessary for actively dividing cells, respectively. Normal tissue 
injury is still a dose-limiting factor of most therapies. Exposure of whole body or significant 
portions (>60%) leads to the development of acute radiation syndrome (ARS). ARS is an 
illness that follows a predictable course. High doses of ionizing radiation above 10Gy are 
lethal due to multiple organ failure. Doses between 1 and 9Gy lead to development of 
hematopoietic syndrome (Goans 2010). Hematopoietic syndrome is characterized by a 
significant drop of hematopoietic cells in blood as a result of hematopoietic stem and 
progenitor cell aplasia (Dainiak 2002; Shao et al. 2010). Thus, the rapid recovery of the 
hematopoietic compartment after therapy improves positive outcomes of life threatening 
pancytopenia – deficiency in all three types of cellular components of blood 
 
1.8 Irradiation stress disrupts hematopoietic stem cell niche signaling 
 
Mouse hematopoietic stem cells were determined to be the most sensitive of all 
mammalian cells undergoing mitotic death upon ionizing radiation exposure (McCulloch et al. 
1962). Relative to hematopoietic progenitors, vascular endothelium has been described as 
radioresistant (Gaugler et al. 1998; Narayan & Cliff 1982). Although the effects of irradiation 
on endothelium are not as strong as on actively proliferating progenitors, it has been shown 
that irradiation causes disruption on the integrity of endothelial barriers (Sharma et al. 2013) 
as well as sloughing of plasma membranes and cytoplasmic swelling (Shirota & Tavassoli 
1992). These processes disrupt the integrity of endothelial cells, leading to the hemorrhage 
of erythrocytes (K. Yamazaki & Allen 1991) and the escape of marrow elements to the 
periphery (Mazo et al. 2002). This ultimately leads to relocation of the HSC into the other 
tissues – a process defined as extramedullary hematopoiesis (Morrison et al. 1997). 
Because endothelial cells have a central role in megakaryopoiesis and stem cell 
homeostasis, integrity of sinusoidal endothelial cells is critical for hematopoietic recovery (F. 
Chen et al. 2017; Doan et al. 2013; Gaugler et al. 1998; Mazo et al. 2002). As bone marrow 
sinusoidal cells function and structure is disrupted following irradiation, improvement of 
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endothelium recovery could facilitate enhanced homeostasis. PHD2 inactivation was shown 
to improve recovery after ischemic injury (Kalucka et al. 2013). Therefore, one critical factor 
that could benefit radiation-based therapy and other stressful treatment is the role of hypoxia 
in the hematopoietic niche. 
 
1.9 Hypoxia induced signaling during recovery after irradiation 
 
Oxygen is a potent chemical radiosensitizer. Shortly after a dose of ionizing radiation, 
the presence of oxygen leads to increased DNA damage (Quintiliani 2009). However, it has 
been shown that 40-60% of all cancer patients that are anemic at the start of radiotherapy 
maintain an overall worse prognosis than patients with normal hematocrit (Varlotto & 
Stevenson 2005). This leads to the hypothesis that hypoxia signaling may be important to 
certain tissues (Gao et al. 2008) in non-pathogenic physiology.  
Endothelial cells are the first cell layer in contact with blood and therefore sensitive to 
oxygen tension. Remarkably, genetic mutations in oxygen sensing proteins (PHD/HIF/VHL) 
in humans are associated with adaptation to high altitudes (Petousi & Robbins 2014) and 
more often with multiple vascular pathologies (Brieger et al. 1999; Smith et al. 2006; Song et 
al. 2014; Talbot et al. 2017). This observation underlines the importance of oxygen sensing 
in the endothelial cell axis.  
Early studies of hypoxia in vitro and in vivo influence the endothelial function. Low 
oxygen partial pressure is associated with increased expression of molecules that facilitate 
neutrophils interactions (Ginis et al. 1993; Baudry et al. 2012).  Hypoxic signaling also 
impacts tissue remodeling by altering expression of vasoconstrictive molecules (Aversa et al. 
1997; Kourembanas et al. 1994). Lastly, remarkable changes in proliferation (Humar et al. 
2002; Li et al. 2007) and survival (Banai et al. 1994; Schäfer et al. 2003) of endothelial cells 
have been observed upon low oxygen levels.   
 Moreover, the expression patterns of endothelial cells change upon hypoxic 
exposure. Examples of specific genes are nitric oxide synthethase (Palmer et al. 1998),  
endothelin – 1 (Aversa et al. 1997), platelet-derived  growth factor B (PDGF-B) 
(Kourembanas et al. 1994), VEGF (Mukhopadhyay et al. 1995) or IL-6 (Yan et al. 1997). 
However, most in vivo studies were performed by exposure of mice to hypoxic conditions. 
Specific endothelial lineage hypoxia signaling was not well understood until recently. 
 At first, genetic engineering enabled studies on hypoxic signaling by ablation of the 
hypoxia sensors PHD1, 2 and 3.  Systemic ablation of PHD2 and not PHD1 and PHD3 was 
determined to be embryonically lethal (Takeda et al. 2006), revealing severe cardiovascular 
defects. PHD1 and PHD3 oxygen sensors play a more compensatory role (Berra et al. 2003; 
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Takeda et al. 2007). In contrast to full knockout, a heterozygous PHD2 led to normalization of 
vasculature in tumor development, leading to decreased metastasis (Mazzone et al. 2009).  
 Conditional knockouts provide an even more exacting view of hypoxia signaling at 
and on endothelial cells. Mice bearing a specific knockout of PHD2f/f in endothelial cells 
display renal vascular and pulmonary hypertension accompanied with early lethality (Dai et 
al. 2016; Kapitsinou et al. 2016; S. Wang et al. 2017). Pulmonary hypertension was a result 
of increased CXCL12 (Dai et al. 2016) Notch3, TGF-b1 (S. Wang et al. 2017) expression in 
endothelial cells. Interestingly, this phenotype is mediated by HIF-2α transcription factor 
(Cowburn et al. 2016). However, these studies utilized conditional knockout mice under 
endothelial specific Tie2, and Cadh5 promoter. Importantly, promoters used for the study 
have been shown to also target the hematopoietic compartment due to the shared embryonic 
progenitor (Joseph et al. 2013). Together, these studies illustrate the critical importance of 
oxygen sensing for endothelial cell signal transduction. Moreover, they revealed a potential 
strategy of hypoxia signaling drug targets in pulmonary hypertension.  
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2 Aims of the thesis 
 
Endothelial cells play an essential role in hematopoietic stem cell regulation and 
maintenance during homeostasis and stress. Many cytokines and growth factors expressed 
by endothelium are required for normal HSC activity. Yet, we still know little of the intricate 
relationship and effects one has on another. Moreover, the primary common function of 
endothelial and hematopoietic cells is ensuring proper oxygen delivery. Role of PHD2 
oxygen sensor and subsequent critical role has been extensively studied in lung vasculature 
(Dai et al. 2016; Kapitsinou et al. 2016; S. Wang et al. 2017) where endothelial cells are at 
the interface of atmospheric oxygen and RBC. However, little is known on the impact of 
oxygen sensor in tissue specific endothelial cells that come in contact with physiologically 
lower oxygen levels. Similiarly, endothelial cells in local tissues play an important role in 
modulation of tissue activity (Winkler et al. 2012).  We know that partial oxygen pressure 
changes the expression of various important cytokines in endothelial cells (Michiels et al. 
2000).  However, we lack the understanding of how PHD2 oxygen sensor impacts the local 
bone marrow environment. Moreover, we do not fully understand the intricate consequences 
of endothelial oxygen sensor initiated signal transduction and its effects on hematopoietic 
stem cells and other hematopoietic stem cell niche residents. Since hypoxia is side effect of 
therapies commonly used in cancer, understanding the signaling propagation could 
potentially lead to discovery of specific targets aiding in improved hematopoietic stem cell 
recovery after dramatic stress.  
 
Aim 1: Determination of the role of endothelial PHD2 on the signaling towards 
the hematopoietic stem cells and its niche.  
 
I sought to determine the impact of the central oxygen sensor PHD2 in endothelial 
cells on hematopoietic stem cells and the niche residents. Using an in vivo approach, I firstly 
pursued to unveil the effects on specific progenitor populations during homeostasis. I utilized 
a unique conditional PHD2 knockout (KO) mouse specific for the endothelial, but not the 
hematopoietic compartment. After validation of this knockout, I first determined whether 
inactivation of PHD2 would lead to alterations in the morphology of the bone marrow 
sinusoidal endothelial cells. Furthermore, I determined whether other bone marrow resident 
cells were changed through inactivation of endothelial PHD2.  
Most importantly, I assessed the impact of EC PHD2 on the activity of hematopoietic 
stem and progenitor cells in the BM and spleen and its subsequent effects on mature cells in 
the periphery.  
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Aim 2: Defining the impact of radiation exposure on the recovery of PHD2-deficient 
endothelial cells and its hematopoietic compartment.  
  
Under stress, formation of newly synthesized vessels and repair of the damaged 
vasculature is an important endothelial cell function (Rubanyi 1993; Penack et al. 2011). A 
relevant model to study endothelial cell recovery in bone marrow is exposure to non-lethal 
doses of ionizing radiation (Korpela & Liu 2014). Endothelial cell recovery is critical for 
hematopoietic stem cell function following cancer therapy (Penack et al. 2011; Poulos et al. 
2015).  Moreover low oxygen levels have been linked with poor outcomes of cancer therapy 
(Dunst 2004) Therefore, I sought to determine whether oxygen sensor PHD2 mediated signal 
transduction influence recovery of endothelial cells and subsequently modulates neighboring 
cells in bone marrow. First I sought to determine effects on recovery and morphology of 
endothelial cells with inactivated PHD2 following ionizing radiation exposure. I then pursued 
to assess the kinetics of hematopoietic cell recovery after myeloablative assault under 
altered endothelial cell specific signaling. Lastly I worked towards revealing specific 
hematopoietic progenitors directly impacted by gene expression changes upon endothelial 
PHD2 inactivation.  
 
Aim 3: Characterization of the influence of the transcription factor HIF-2α in mice 
lacking EC PHD2 
 
HIF-1α and HIF-2α are common transcription factors through which the PHD2 signal 
is transduced. Specifically, both HIF-1α (Gerber & Johnson n.d.) and HIF-2α (Skuli et al. 
2009; Kapitsinou et al. 2016; Dai et al. 2016; S. Wang et al. 2017) have been shown to be 
essential for endothelial homeostasis and angiogenesis. However, only HIF-2α has been 
shown to be responsible for response and translational activation in homeostasis and 
following injury (Kapitsinou et al. 2016; Kapitsinou et al. 2014; Dai et al. 2016; Skuli et al. 
2009). I sought to determine the impact of the transcription factors regulated by PHD2 in 
vivo. I made a unique conditional double knockout (DKO) mouse where PHD2 along with 
HIF-2α has been ablated in endothelial cells. If PHD2 inactivation was mainly mediated by 
HIF-2α transcription factor then I DKO would result in the potential rescue of the phenotypes 
induced by the loss of EC PHD2. I therefore determined the changes in endothelial and 
hematopoietic compartment in DKO mice. Reversal of phenotypic differences between the 
single KO and its WT littermate would strongly suggest for a central role of HIF-2α in the 
mediation of the PHD2 signal transduction. 
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3 Materials and methods 
3.1 Mice.  
 
All mice used in this thesis were born have Mendelian birth distribution. To assure proper 
background mouse strains were at least nine times backcrossed to C57BL/6. Genotyping to 
determine genetic status of litters was performed using primers described in Table 1. 
Penetrance in KO was determined via qRT-PCR on EC and hematopoietic mature cells and 
genomic PCR on ear and tail biopsies. Mice were housed at the Experimental Centre at the 
University of Technology Dresden (Medical Faculty, University Hospital Carl-Gustav Carus), 
under specific pathogen free conditions. Adult male and female mice at the age of 8-12 
weeks or as stated in the text were used for the experiments. All animal experiments were in 
accordance with the facility guidelines on animal welfare and were approved by the 
Ladesdirektion Dresden, Germany (TVV 16/2016; TVV 66/2016) 
 
Table 1 List of primers used to genotype mice. 
 
 
3.2 Histology, immunohistochemistry and immunofluorescence staining 
 
3.2.1 Tissue processing prior to staining:  
 
For cryopreservation: WT and KO Mice (2-3 months old) were sacrificed. For calcified 
tissue bones were fixed overnight in 4% paraformaldehyde (sigma-Aldrich), washed in PBS 
(pH 7.2) and decalcified in Richard Alan Solution (Thermo scientific) for 2 hours at room 
temperature. Sections were prepared for cryopreservation by incubation in 10%, 20% and 
Cre recombinase Fw 5´ GCC TGC ATT ACC GGT CGA TGC AAC GA 3´ 
Cre recombinase Rev 5´ GTG GCA GAT CGC GCG GCA ACA CCA TT 3´ 
PHD2 exon2 5´ CGC ATC TTC CAT CTC CAT TT  3´ 
PHD2, intron1 5´ CTC ACT GAC CTA CGC CGT GT  3´ 
PHD2 intron3 5´ GGC AGT GAT AAC AGG TGC AA  3´ 
HIF2α1 5´ CAG GCA GTA TGC CTG GCT AAT TCC AGT T  3´ 
HIF2α2 5´ CTT CTT CCA TCA TCT GGG ATC TGG GAC T  3´ 
HIF2α3 5´ GCT AAC ACT GTA CTG TCT GAA AGA GTA GC  3´ 
ROSA WT Fw 5´ CTC TGC TGC CTC CTG GCT TCT 3´ 
ROSA WT Rev 5´ CGA GGC GGA TCA CAA GCA ATA  3´ 
ROSA MTMG Rev 5´ TCA ATG GGC GGG GGT CGT T 3´ 
17	
	
30% sucrose for 24 hours at 4°C, and embedded in OCT (Tissue-Tek). Sections were cut 
using a Cryostat NX50 (Thermofisher) air-dried in RT for 20min. And stored in -20°C.  
 
For paraffin embedded samples: WT and KO Mice (2-3 months old) were sacrificed. For 
calcified tissue bones were fixed overnight in 4% paraformaldehyde (sigma-Aldrich), washed 
in PBS (pH 7.2) and decalcified in Richard Alan Solution (Thermo scientific) for 2 hours at 
room temperature. Bones then were dehydrated, embedded in paraffin and cut. For other 
samples organs, tissues were places in 4% paraflormaldehyde at 4°C overnight, dehydrated, 
embedded in paraffin and cut. 
For other tissues: tissues were dehydrated, embedded in paraffin and cut. Slides were stored 
in RT.  
 
3.2.2 Staining:  
 
For cryopreserved sections: Slides were fixed in acetone for 10min and allowed to air dry 
for at least 30min. Slides were washed 3x in wash buffer (PBS/0,1% Triton-X100). Next 
slides were blocked with blocking solution (wash buffer + 5% BSA, 0,1% Triton-X100) for at 
least 20min at room temperature in a humidified chamber to block non-specific antibody 
binding. Samples were incubated with primary antibody in appropriate dilution (in blocking 
solution) overnight at 4°C. The technical negative control did not have primary antibody 
(Table 2).   
 
For paraffin embedded sections: Slides were deparafinised in roticlear twice for 10min, 
followed by rehydration through a descending ethanol series then washed in PBS. Antigen 
retrieval was carried out in citrate buffer in a steamer for 15min, followed by washing 3x in 
wash buffer. Samples were incubated with primary antibody in appropriate dilution (in 
blocking solution) overnight at 4°C. The technical negative control did not have primary 
antibody (Table 2).   
 
3.2.2.1 Immunofluorescence 
 
After incubation with primary antibody, slides were washed three times with wash buffer and 
incubated with appropriate secondary antibody (as specified in figure legends) conjugated to 
fluorophore for 2hr at room temperature. For staining of cells nuclei DAPI (4’,6-diamidino-2-
phenylindole) was used at concentration of 1µg/ml. Slides were then washed and mounted to 
the cover slips with DAKO Cytomation Fluorescent Mounting Medium.  
18	
	
 
3.2.2.2 Immunohistochemistry:  
 
After primary antibody incubation slides were washed three times with wash buffer and 
incubated with appropriate secondary antibody coupled to biotin for 1hr at room temperature. 
Slides were then washed and incubated with avidin conjugated HRP according to 
manufacturer’s directions. After washing procedure slides were then processed with the AEC 
kit according to manufacturer’s instructions. Substrate development was monitored with 
bright-field microscopy; to stop the reaction the slides were washed in water. Sections were 
counterstained with hematoxylin and mounted to cover slips with Aquatex mounting medium.  
 
Sections were imaged on and Leica SP 5 confocal microscope (Leica) or white field 
Axioscan microscope. 
 
Table 2. List of primary antibodies used for staining 
Antibody Dilution used for IHC/IF Company, manufacture 
number 
Endomucin 1:200 Ebioscience, 14-5851-82 
Anti-GFP antibody 1:200 Thermo Fisher, A-6455 
Smooth muscle actin 1:200 DAKO, IA4 
CD41 FITC 1:100 eBioscince,  
 
 
3.3 Endothelial cell sorting  
 
Cell sorting was performed on AriaII (Bectond Dickinson). Data was analyzed on Flojo 
(Treestar) software. Briefly, mice were sacrificed and femurs crushed using a mortar and 
pestle, and WBM was washed away. Bone endothelial cells were enzymatically 
disassociated in DMEM (Life Technologies, Thermo Fisher Scientific), 3 mg/ml collagenase 
type 1 (Cell systems), and 1 ug/ml DNAse II (Qiagen) for 60 minutes at 37°C with gentle 
agitation. Cell suspensions were filtered (100-µm), washed in PBS (pH 7.2) containing 5% 
FCS. To determine endothelial and stromal cell populations via flow cytometry, the resulting 
cell suspensions were stained using antibodies against CD31 (APC, 390, ebioscience), 
CD45 (Pe-Cy7, 30-F11 BioLegend), and TER119 (Pe-Cy, TER119 Thermofisher), Sca1 
(PeCy5, D7, ebioscience); Endothelial and stromal cell populations were defined as 
Sca1+CD31+CD45–TER119– and Sca1–CD31–CD45–TER119–, respectively. 
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3.4 Mature hematopoietic cell isolation 
 
The peripheral blood (one capillary) was obtained retro-orbitally. Erythrocytes were lysed 
using ACK lysis buffer (Gibco) by performing two incubations of 5 min each. Washed 
leukocytes then were processed further to determine PHD2 expression. 
 
3.5 Expression analysis 
 
RNA was isolated using NucleoSpin RNA XS(Macherey-Nagel). Synthesis of cDNA was 
performed by using random primers (Roche) and SuperScript II (Invitorgen) reversed 
transcriptase according to manufacturers protocol. Levels of mRNA expression were 
determined by quantitative real-time PCR using the Maxima SYBR green Master Mix 
(Fermentas) on an iCyber iQ (Biorad). Primer sequences used for determination of mRNA 
levels are listed in Table 3. Expression levels wee normalized with the ΔΔCt method using 
household genes.  
 
Table 3 List of qRT-PCR primers used 
PHD2 forward 5’	AAG	CCC	AGT	TTG	CTG	ACA	TT	3’	
PHD2 reverse 5’	CTC	GCT	CAT	CTG	CAT	CAA	AA	3’	
mTBP forward 5’	TCT	ACC	GTG	AAT	CTT	GGC	TGT	AAA	3’		
mTBP reverse 5’	TTC	TCA	TGA	TGA	CTG	CAG	CAAA	3’	
EF2 forward 5’	AGG	CCG	CCA	TGG	GTA	TTA	AG	3’	
EF2 reverse 5’	TTC	AGA	CCT	GTG	GAC	ACC	ACC	3’	
B2M forward 5’	ATG	CAC	GCA	GAA	AGA	AAT	AGC	AA	3’	
B2M reverse 5’	AGC	TAT	CTA	GGA	TAT	TTC	CAA	TTT	TTG	AA	3’	
 
3.6 Hypoxyprobe  
 
To evaluate BM oxygenation status, WT and KO mice were injected intra peritoneal (i.p.) with 
120 mg/kg of 100mg/ml pimonidazole HCl (Hypoxyprobe-1; Hypoxyprobe Inc.). Femurs were 
isolated and treated according to standard tissue processing protocol (section 3.2.1, 3.2.2). 
Sections were stained with endomucin and anti-piminizadole A594 antibody overnight in 4C. 
Following wash, secondary antibody to visualize endomucin - anti-goat (A488) was incubated 
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for 2hrs at RT. Sections were counterstained with 1 µg/ml DAPI and mounted with 
fluorescence mounting medium (DAKO).  
 
3.7 Quantitative image analysis 
 
Quantitative image analysis was performed as previously described (Collinet et al. 2010; 
Schindelin et al. 2012). Briefly, the vasculature analysis was performed with ImageJ 
(Schindelin et al. 2012) by quantification of area of each vessel. The sum of the areas of 
each vessel was referred to as total area of vessel in region of interest. The sum of number 
of vessels in one image was referred to as number of vessels per region of interest. 
Quantification of NG2 signal was performed by using Motion Tracking software (Collinet et al. 
2010), briefly, the endomucin signal was used as a reference to mask the area around 
vasculature within one cell width. MFI of the NG2 signal within the masked area was then 
quantified and divided by the total area surveyed to normalize the results.  
 
3.8 Bone structure analysis 
 
Bone analysis was performed as previously described (Colditz et al. 2018). Briefly, the fourth 
lumbar vertebra, distal femur, and femoral shaft analysis was performed with a vivaCT 40 
(Scanco Medical, Bruttisellen, Switzerland) with an X-ray energy of 70kVp (114mA, 200ms 
integration time) and an isotropic voxel size of 10.5 mm. The vertebral body and distal femur 
analysis parameters were calculated from 100 slices using the Scanco bone evaluation 
software. Analysis of cortical bone parameters were calculated from 100 slices at the femoral 
mid-shaft using the cortical bone evaluation program from Scanco. Presented results are in 
accordance to the American Society for Bone and Mineral Research guidelines (Bouxsein et 
al. 2010). 
 
3.9 Blood analysis 
	
One capillary of peripheral blood (60µl) was obtained retro-orbitaly and diluted 5x with PBS. 
Peripheral blood parameters (HCT, RBC, HGB, PLT, WBC, LYMPH, NEUT, MONO) were 
measured using a Sysmex automated blood cell counter (Sysmex XT-2000i).  
Plasma erythropoietin levels were assessed using the quantitative mouse ELISA kit for 
erythropoieitin (Cloud-Clone Corp.).  
For analysis of blood recovery after non-lethal radiation no more than one capillary was 
taken from the mice every week.  
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3.10 FACS analysis  
	
FACS analysis was performed on LSRII (Becton Dickinson) or AriaII (Becton Dickinson). 
Total cell numbers were determined by using MACS quant. Data was analyzed on Flowjo 
(Treestar) software. As diluent for antibody mix and wash buffer I used PBS supplemented 
with 2% FCS. Single cell suspensions were prepared by crushing one femur and two tibias 
per mouse (for cells from bone marrow) or by macerating the spleen between two slides (for 
spleen). Cell suspension were always filtered with 40um mesh after isolation and directly 
before FACS analysis.  
 
For HSC and myeloid precursors staining: BM cells were incubated first with lineage mix 
containing biotinylated antibodies: CD3 (145-2C11, eBioscience), CD19 (eBioscience). 
NK1.1 (PK136, eBioscience) Ter119 (Ter119, eBioscience), CD11b (M1/70, eBioscience), 
GR1 (RB6-8C5, eBioscience) and B220 (RA3-6B2, eBioscience). Incubation was for 30min 
on ice. After washing cells were further incubated with HSPC mix containing fluorophore 
conjugated antibodies: c-Kit (A780, 2B8, eBioscience), Sca1 (PE-Cy5, D7, eBioscience), 
CD48 (APC, HM48-1, eBisoscience), CD150 (PE-Cy7, TC15-12F12.3, Biololegend) CD105 
(PE, MJ7/18) CD16/32 (A700, 93, eBioscience) CD41 (PerCP-eFluor 710, MWReg30) 
eBioscience) and streptavidin conjugated to eF450 (SAeF450, eBioscience) for 40min on ice. 
3,5x106 cells were acquired with exclusion of RBC by size. This marker combination allowed 
me to distinguish all the progenitors previously described (Kiel et al. 2005).  
 
Table 4 Surface marker combination used for distinguishment of splenic and bone marrow HSPC 
Progenitor: Marker combination 
KLS Lin-Sca1+cKit+ 
HSC Lin-Sca1+cKit+CD48-CD150+ 
MPP2 Lin-Sca1+cKit+CD48+CD150+ 
MPP3/4 Lin-Sca1+cKit+CD48+CD150- 
MkP Lin-Sca1-cKit+CD41+CD150+ 
GMP Lin-Sca1-cKit+CD41-CD150-CD16/32+ 
preGM Lin-Sca1-cKit+CD41-CD150-CD16/32-CD105- 
preMegE Lin-Sca1-cKit+CD41-CD150+CD16/32-CD105- 
CFUe Lin-Sca1-cKit+CD41-CD150-CD16/32-CD105+ 
preCFUe Lin-Sca1-cKit+CD41-CD150+CD16/32-CD105+ 
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For the lymphoid progenitor assessment the lineage positive cells were excluded using the 
same cocktail of biotinylated antibodies as the one used for HSCs. Additionally, cells were 
stained with c-Kit (A780, 2B8, eBioscience), Scal1 (Pe-Cy5, D7, eBioscience), CD135 (PE, 
A2F10, eBioscience), CD127 (A700, A7R34, eBioscience) and SA (EF450, eBioscience). 
Lymphoid preogenitor population is characterized as Lin-Sca1lowcKitlowCD127+CD135+. 
 
For erythroblast population BM or splenic cells were stained with Ter119 (PE-Cy7, TER-119, 
Thermofisher) and CD44 (APC, IM7, eBioscience). Erythroblast population gating is 
described in Figure 36 
 
For B lymphocyte compartment in the spleen splenic cells were stained with CD23 (PacBlue, 
B3B4, Biolegend), CD21/35 (PE-Cy7, CR2/CR1, Biolegend) CD19 (FITC, MB19-1 
eBiosciece) IgM (APC, RMM-1, Biolegend) B220 (A700, CD45R, eBioscience) IgD (PE, 11-
26c.2a, Biolegend ) CD93 (PerCP/Cy5.5, AA4.1, Biolegend) and SA (A780, eBioscience) to 
exclude biotynylated GR1 (RB6-8C5, eBioscience) and CD11b (M1/70, eBioscience).  
 
Table 5 Surface marker combination used to distinguish spleen B cell progenitor and B cell subsets 
Cell population Surface markers 
T1 – transitory progenitor 1 CD11b-GR1-CD19+CD21/35-IgM+CD93+CD23- 
T2 – transitory progenitor 2 CD11b-GR1-CD19+CD21/35-IgM+CD93-CD23- 
Marginal Zone progenitors CD11b-GR1-CD19+CD21/35-IgM+B220+CD23+ 
Maginal Zone B cells B220+CD23+ CD21/35med 
Folicular cells B220+CD23- CD21/35high 
 
 
For calculation of total bone marrow cellularity the erythrocytes and doublets were excluded 
electronically using flowjo. Total cellularity was determined by selective selection on live and 
CD45 positive cells. Percentages of various populations obtained via flow analysis were 
multiplied back to total cellularity to achieve absolute numbers of different fractions.  
 
3.11 Cell cycle analysis 
	
Lineage depletion was done prior to surface staining. Briefly, cells were incubated with 
biotinylated lineage antibody cocktail. After washing the residual antibody cells were 
incubated with and streptavidinated magnetic beads (Anti-biotin Microbeads (MACS), 
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Miltenyibiotec) and separated using magnetic columns (LS column, Miltenyibiotec). Flow 
through was then stained with appropriate surface marker combination. For intracellular 
staining the cells were then fixed and permeabilized using fixation and permeabilisation 
buffers from eBioscience. For distinction between G0 and G1 phase, cells were stained for 
intracellular ki-67 (FITC, B56, BD Bioscience). Cells were saturated with DAPI (5mg/ml) 
(molecular probes) to measure the DNA content and separate the cells in S/G2/M phase 
from the G0 and G1 cells. For gating strategy refer to Figure 28. 
 
3.12 RBC transfusion 
	
For analysis of RBC production I followed already described protocol (Dholakia et al. 2015). 
Briefly, whole blood was collected into sterile tubes from UBC-GFP mice with anticoagulant 
heparin solution. The anticoagulated blood (150µl per mouse) was administered to the 
recipient mice via retro-orbital injection. Total amount of blood was no greater than 7,5% of 
total body weight to exclude suppression of normal erythropoiesis.  
 
3.13 Statistics.  
	
No statistical models were used to predetermine experimental sample sizes. All bar graphs 
and line graphs are displayed as the mean ± SD, and significance was determined using the 
Mann-Whitney U test, with the threshold set at a P value of less than 0.05. Statistical 
significance and graphs were quantified and devised by using Graphpad Prism 7.0 software. 
Statistical significance represented by * symbol mean – *(P≤0,05), **(P≤0,01), ***(P≤0,001), 
****(P≤0,0001) 
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4 Results 
 
 
 
4.1 Determination of the role of endothelial PHD2 on the signaling 
towards the hematopoietic stem cells and its niche  
4.1.1 Validation of the Flk1:cre line endothelial cell targeting 
4.1.1.1 Flk1cre mouse models targets only endothelial and not other bone 
marrow resident cells 
	
To study the role of endothelial PHD2 on hematopoietic stem cells we developed an 
endothelial specific PHD2-deficient mouse line. Several groups have described conditional 
PHD2 knockout mouse models (Dai et al. 2016; Kapitsinou et al. 2016). However, the two 
different mouse models used in these studies are not endothelial specific but also target at 
least part of the hematopoietic compartment (K. Choi et al. 1998). We sought to generate a 
mouse that would be endothelial specific without an effect on the hematopoietic 
compartment. We reasoned that Flk1 promoter due to its “late” embryonic activation would 
target only endothelial cells. 
To ensure endothelial specificity within bone marrow resident cells, we generated a 
reporter mouse line by crossing a Flk1:cre line (Licht et al. 2004) with a mTmG double 
reporter mouse (Muzumdar et al. 2007). The Flk1:cre-mTmG mouse line expresses 
membrane-targeted tandem dimer mT prior to cre-mediated excision. Upon cre activity, mT 
is excised from endothelial cells, and membrane targeted (mG) green fluorescence protein 
(GFP) is expressed. In summary, only cells targeted by Flk1 promoter driven cre are GFP 
positive.   
The Flk1:cre-mTmG mouse line enables me to directly observe the cell specificity of 
the knockout using fluorescence methods. Due to the prominent heterogeneity of bone 
marrow residents, confocal microscopy is the most powerful tool of assessment specificity of 
the mouse without the need of isolation of multiple cell types. I co-stained bone marrow 
sections with anti-GFP antibody (green), sinusoidal endothelial maker – endomucin (red) and 
nuclei dye DAPI (blue). Control, cre negative mice, was negative for the GFP signal, which 
assured the specificity of the anti-GFP antibody in this assay. Cre+ reporter mice analysis 
displayed a precise colocalization of GFP-expressing cells with endomucin positive 
endothelial cells, but not other bone marrow resident cells visualized by DAPI staining (Fig. 
25	
	
8). This result indicates that targeting of the Flk1:cre promoter in the bone marrow is 
endothelial cell specific and does not affect hematopoietic cells or other bone marrow 
residents.  
	
Figure 8 Cre activity in Flk1:cre mice is restricted to endothelial cells. Bone marrow sections of cre+ 
Flk1:cre-mTmG and cre- mTmG. 10μm thick sections were stained with DAPI (shown in blue), anti-GFP antibody 
(A488 shown in green), and endomucin (A549 shown in red). Images were taken on a confocal microscope with 
40x magnification. A cre- mouse is used as a negative control. 
 
Endomucin targets sinusoidal endothelial cells and is not a good marker for arteriolar 
endothelial cells. However, arterioles and sinusoids differentially express the common stem 
cell marker Sca1. Therfore, I utilized FACS to distinguish Sca1 positive arterioles from 
hematopoietic stem cells expressing high levels of this marker. I first distinguished stromal 
cells from the hematopoietic compartment by excluding cells expressing both the CD45 and 
Ter119 surface makers (Fig. 9a). CD45 is a hematopoietic lineage-restricted antigen 
expressed in all hematopoietic cells except for mature erythrocytes and platelets. Mature 
erythrocytes can be excluded by presence of specific marker Ter119, and platelets are 
excluded based on size. The non hematopoietic population of CD45-and-Ter119 negative 
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cells can be further divided into endothelial and non-endothelial cells by differential 
expression of CD31+ (Kusumbe et al. 2014) with high levels of CD31 expression specific for 
endothelial cells (Fig. 9c).  
FACS analysis of Flk1:cre-mTmG reporter mice revealed that 70% of arterioral 
endothelial cells were positive for the GFP signal (Fig. 9d), indicating a high degree of cre 
specificity. However, the hematopoietic compartment (CD45+, Ter119+; Fig. 9b) as well as 
other stromal cells (CD45-Ter119-CD31-; Fig. 9e), did not express GFP, as expected.  
	
Figure 9 Gating strategy for FACS analysis of Flk1:cre-mtmg mouse. After doublet discrimination, 
hematopoietic cells are distinguished by high levels of expression of Ter119 and CD45 surface markers (a). 
These cells were not characterized by presence of GFP (b) showing lack of targeting with Flk1:cre. Cells that did 
not express Ter119 and CD45 markers on their surface (a) can be further divided into two populations: stromal 
cells not expressing CD31 surface marker and arteriolar endothelial cells (AEC) expressing high levels of CD31 
and Sca1 surface markers (c). Each of these populations were analyzed for GFP expression (e) and (d) 
respectively. 
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These results confirm the endothelial cell-specific targeting of Flk1:cre within bone 
marrow environment. Therefore, the Flk1:cre mouse model is ideal for the study of loss of 
PHD2 in endothelial cells and its subsequent effect on bone marrow resident cells. It 
provides a unique and powerful tool to understand the impact of endothelial oxygen sensor 
on neighboring bone marrow cells.  
 
4.1.1.2 High degree of PHD2 knockdown in endothelial cells of Flk1:cre-PHD2f/f  
 
To generate this novel, endothelial specific PHD2-knockodown line, PHD2 floxed 
mice (Singh et al. 2013) were crossed with the Flk1 promoter/enhancer- driven cre 
transgenic mouse line (Licht et al. 2004) resulting in Flk1:cre-PHD2f/f mice. For the remainder 
of the thesis this conditional deficient mouse line is referred to as “KO”.  
To validate this mouse, I first demonstrated the level of PHD2 in sorted endothelial 
cells using fluorescence activated cell sorting (FACS) (>95% sort purity), followed by 
quantitative real time PCR (qRT-PCR). KO endothelial cells had ~80% downregulation of the 
gene expression in comparison to WT littermates (Fig. 10a). To provide quantitative evidence 
that the hematopoietic cells are not targeted in this line, I isolated blood cells and assessed 
for PHD2 gene expression by qRT-PCR. Gene expression analysis of PHD2 transcripts 
displayed no difference between KO and WT hematopoietic cells (Fig. 10b). These results 
suggest that the conditional KO mouse Flk1:cre-PHD2f/f indeed targets endothelial cell 
progenitors without targeting hematopoietic compartment.   
	
Figure 10 qRT-PCR analysis of PHD2 expression in Flk1:cre-PHD2f/f mouse. Analysis of sorted a) endothelial 
cells and b) peripheral hematopoietic cells.  Data is presented as Mean ± SD. Statistical significance was 
calculated using the Mann-Whitney U test. 
 
This result indicates a high degree of endothelial cell specific targeting of PHD2 
ablation proving Flk1:cre-PHD2f/f is the ideal mouse model to study the role of the endothelial 
PHD2 oxygen sensor and its subsequent effects on the hematopoietic compartment.  
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4.1.2 Characterization of the endothelial cell morphology and vessel function 
upon PHD2 inactivation 
	
4.1.2.1 Loss of PHD2 in endothelial cells leads to pulmonary vessel thickening  
 
 The effects of oxygen sensing at the organism level broadly leads to the 
enhancement in oxygen delivery and activation of the mechanisms to reduce oxygen 
consumption (Bunn & Poyton 1996). On a systemic level, hypoxia leads to hyperventilation, 
increased heart output, erythropoiesis and vascular changes (José López-Barneo et al. 
2003). However, all cells are oxygen-sensitive and will respond to the local oxygen levels by 
alterations of their signaling pathways. Ablation of PHD2 cells results in the stimulation of 
gene expression associated with a sensing of hypoxia by endothelial cells (Semenza 2003).  
 A major effort has been made to understand the effect of hypoxic signaling in 
pathogenic models. Specifically, oxygen sensor in endothelial cells changes the tumor 
endothelial morphology, leading to an increased oxygenation of tumor tissue (Mazzone et al. 
2009). More recently, endothelial cell conditional PHD2 KO mice were reported to exhibit 
pulmonary hypertension (Dai et al. 2016; Kapitsinou et al. 2016; S. Wang et al. 2017). These 
mouse models displayed enhanced muscularization of peripheral pulmonary arteries, as 
assessed by positive staining for alpha smooth muscle actin (αSMA), and the pathological 
thickening of the vessels (Dai et al. 2016; Kapitsinou et al. 2016).  
 I hypothesize that the Flk1:cre-PHD2f/f endothelial specific mouse model will 
confirm the impact of role of PHD2 on pulmonary endothelial changes. To strengthen the 
endothelial specific mouse model used for this study, I examined the lung vasculature and 
morphology of pulmonary arterioles, and I observed thickening of pulmonary arterioles in KO 
mice (Fig 11).   
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Figure 11 Pathological lung vasculature in Flk1cre-PHD2f/f knockout mice as compared to WT littermates. 
Haematoxylin and eosin staining of 5um thick lung sections taken from 8 week old mice showing thickening of 
vascular endothelial cells. The sections were imaged by a white field scanning microscope at 10x magnification. 
The vasculature is visualized by the white arrows. The scale bar represents 200µm.  
 
4.1.2.2 Loss of PHD2 in endothelial cells does alters overall bone marrow 
vascular structure 
 
To determine the alterations of bone marrow sinusoidal endothelial cells, I compared 
sections obtained from WT and KO mice. I first observed no differences between bone 
marrow structure of the WT and KO mice (Fig 12a). Then I assessed the bone marrow 
vasculature by immunohistochemistry analysis of endomucin positive sinusoidal endothelial 
cells. The staining revealed high vascularization of both WT and KO marrow with a regular 
capillary distribution (Fig 12b). To determine the quantitative changes in bone marrow total 
cellularity, I utilized FACS. The total cell number of CD45 positive hematopoietic cells in the 
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bone marrow remained unchanged between WT and KO littermates (Fig. 12c). This result 
indicates no obvious changes in bone marrow structure and organization. However 
preliminary staining of endothelial cells suggests vessel structure differences. 
	
Figure 12 Vascular and bone marrow structure differences between WT and KO mice. (a) 10µm thick 
femoral bone marrow paraffin sections were stained with haematoxylin and eosin. The scale bar represents 
50µm. (b) Bone marrow sections of endomucin (brown) stained by the immunohistochemistry and co-stained with 
Haematoxylin. The scale bar represents 100µm. (c) Total cell number of CD45+ live cells obtained from two 
independent experiments n=11. The Data is presented as Mean ± SD. Statistical significance was calculated 
using the Mann-Whitney U test. 
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4.1.2.3 Loss of PHD2 in endothelial cells leads to vasodilation of bone marrow 
sinusoidal vessels 
	
The immunohistochemistry images indicated alteration in the morphology of the 
vasculature. To quantitate the changes in the vascular lumen, I used immunofluorescence 
analysis of the sinusoidal endothelial vessels. I chose the endothelial specific marker 
endomucin (shown in red) to specifically distinguish the endothelial cells lining the sinusoids, 
while the other cell types can be visualized by nuclear DAPI staining (blue) (Fig. 13a). I 
quantified the changes to the vessel number, lumen and total lumen of vessels per area by 
quantitative image analysis (Schindelin et al. 2012). First, I analyzed the number of vessels 
in a selected region of interest. Each vessel’s size was determined by measuring its lumen 
area. Lastly, the total lumen of all vessels in the region of interest was determined in order to 
compare the overall changes in the bone marrow area/endothelial lumen area ratio. 
Quantitative image analysis revealed that the KO mice vessel lumen area increased in 
comparison to the area of the WT vessels (Fig. 13b). This increased size of vessels 
consequently resulted in a reduction of vessel number per area analyzed (Fig. 13c). These 
results are consistent with the significant increase in the total area of vessels per entire 
region quantified in KO mice (Fig. 13d). The complexity of the network can be estimated by 
measuring the ratio of the total area to the number of vessels (Fig. 13e). Together, the data 
confirms that the complexity of the endothelial vessel has increased leading to vessel’s 
dilation and subsequent decrease of vessel number upon PHD2 inaction related signaling.  
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Figure 13 Changed morphology of bone marrow endothelium in Flk1:cre-PHD2f/f KO mice. (a) Confocal 
microscopy (60x magnification) of the immunofluorescent images of 10µm paraffin sections of bone marrow 
obtained from WT and KO littermates depict nuclei (blue) and endothelial cells (red). Scale bar represents 10 µm. 
Quantitative analysis of vessels depicting vessel lumen area (b), vessel number (c), total area of vessels in 
quantified region (d), and vessel complexity (e) are represented as the ratio of the total vascular area and vessel 
numbers. The data obtained from the analysis of images from 3WT and 5KO mice.  The Data is presented as 
Mean ± SD. Statistical significance was calculated using the Mann-Whitney U test. 
 
4.1.2.4 Loss of endothelial PHD2 might lead to slight tendency in oxygenation 
of bone marrow upon 
 
Interestingly, it has been shown that tumors developing in mice heterozygous for 
PHD2 were decreased in amount of hypoxic areas (Mazzone et al. 2009), illustrating the 
relation of oxygen sensing  and oxygen delivery. Bone marrow is a hypoxic 
microenvironment with a partial oxygen pressure varying from 1-4% (Spencer et al. 2014). I 
hypothesize that increased vessel lumen will lead to change and increase in their 
permeability and thus, increased tissue oxygenation. To evaluate this in my endothelial-
specific PHD2 inactivated mouse model, I assessed bone marrow oxygenation using 
pimonidazole staining. Preliminary data from immunofluorescent staining (Fig. 14a) did not 
revealed any significant differences in hypoxic areas of KO mice relative to the WT 
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littermates (Fig 14b). However, due to the heterogeneity of the bone marrow slight tendency 
of decrease was evident. This experiment shall be repeated with larger areas of bone 
marrow analysed to obtain definitive answer. 
	
Figure 14 Bone marrow of KO mice is prone to increased oxygenation. (a) 10µm bone marrow sections were 
stained with fluorescently labeled antibody against pimonidazole (red) and DAPI (blue). The images were taken 
with an Axioscan microscope with 10x magnification. Scale bar represents 200µm. (b) Quantitative analysis of the 
hypoxic area per region of interest. The data are obtained from one experiment 3WT vs 3KO with 15 images 
analyzed for each. The Data is presented as Mean ± SD. Statistical significance was calculated using the Mann-
Whitney U test.  
  
4.1.3 Loss of endothelial PHD2 leads to a decrease in bone marrow niche 
	
   
The hematopoietic stem cell niche is a dynamic environment. Here cells are 
dependent on signaling from neighboring niche residents. Endothelial PHD2 oxygen sensing 
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induced signaling could indicate an emergency state to the neighboring cells therefore, I 
hypothesize that endothelial PHD2 ablation will result in a decrease of cells residing in the 
niche. To assess alterations of the niche components, I sought to examine two important 
niche contributors, known to be closely associated with endothelial cells: osteoblasts and 
pericytes. 
 
4.1.3.1 Loss of PHD2 in endothelial cells leads to a profound decrease in bone 
metabolism.  
 
Growing evidence suggests that endothelial cell signaling influences bone remodeling 
(Alam 1992; Kasten et al. 1994). Osteogenesis has been shown to be dependent on the 
angiogenic activity of endothelial cells during development (Trueta & Buhr 1963) and in adult 
mice (Kusumbe et al. 2014).  
Bone is a very heterogeneous tissue with plethora of different activity and oxygen 
requirements. The mineralized bone tissues can be divided into compact and trabecular 
bone. Compact bone, also known as cortical, forms the outer shell of most bones and 
contributes ~80% of the weight of a human skeleton. This microscopically compact tissue 
has high density and mineralization with low levels of bone remodeling (Fig. 15a). Compact 
bone supports body weight, protects organs, as well as stores and releases calcium when 
systemically necessary. In contrast, trabecular bone, also known as cancellous, is found in 
the vertebrate and at the end of long bones (Fig. 15a), and is a porous foam-like structure 
that is characterized by lower density, strength and stiffness. Interestingly, cancellous bone is 
a more dynamic tissue, with both higher remodeling and surface area than cortical skeletal 
tissue (Fig. 15b). Trabecular bone is highly vascularized and contains the red bone marrow 
where hematopoiesis occurs.  
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Figure 15 Two types of mineralized tissues in bone. 3D reconstruction of femoral representative example of 
Fl1cre-PHD2f/f WT mouse depicts two types of mineralized tissue – trabecular and cortical bone. The images 
were reconstructed using micro-computing tomography (µCT). The scale bar indicates 1.0mm (a) and 100 µm (b) 
 
To test the hypothesis that PHD2 oxygen sensor induced signaling affects bone, I 
examined the weight of the WT and KO bones. To adjust for body size, I normalized femur 
weight to total body weight. I did not observe significant differences in bone size (Fig 16a). 
However, overall size is influenced by many factors and may betray smaller scale changes. 
The cortical bone contributes 80% of the weight of a human skeleton, thus I first focused on 
the cortical tissue. Microscopic analysis of the cortical bone of skeletally mature mice 
revealed slight but significant decrease in total bone volume in KO mice (Fig. 16b). This 
reduction was a result of significantly decreased cortical thickness in KO mice relative to WT 
littermates. Cortical bone mineralization was not changed. This result could indicate a 
decrease in bone remodeling.  
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Figure 16 Flk1:cre-driven PHD2 deletion from endothelial cells reduces bone mineral density. Measures of 
bone weight and density were performed in 8-week-old KO and their respective WT littermates. (a) Normalized 
femur weight in shown in respect to total body weight. (b) Peripheral quantitative computed tomography results 
measure cortical bone mineralization, bone volume density and thickness. Data is presented as Mean ± SDData 
is presented as Mean ± SD. Statistical significance was calculated using the Mann-Whitney U test. 
 
Trabecular and cortical bone morphology is characterized using micro-computed 
tomography (µCT). This methodology allows for an assessment of three-dimensional 
structures by using X-ray attenuation and then reconstruction of the 3D structure of the 
specimen. µCT assessment of bone mass and morphology allows for the rapid analysis of 
measurements such as the mean trabecular number, thickness or spacing. Bone mineral 
density is characterized as the amount of bone mineral in bone tissue – it assesses bone 
quality. Similarly, trabecular number, thickness and spacing describe the topology and 
morphology of cancellous bone.  
µCT analysis of trabecular bone (Fig. 17a) revealed significantly lower bone density 
and bone volume in the appendicular (femur) (Fig 17b) and axial (vertebrae) (Fig. 17) 
skeleton of KO mice. I observed a decrease in both femoral bone volume and vertebrae 
trabecular bone. Similarly, analyses of cancellous bone revealed a decrease in femoral 
trabeculae number and vertebral trabeculae number. Consequently, spacing between 
individual trabeculae increased with statistical significance in the vertebrae and I observed 
tendency to an increase of trabecular spacing in femur. No statistically significant changes 
were observed in both axial and appendicular skeleton trabecular thickness but a tendency 
of decrease was noted: mean femoral trabeculae thickness decrease (p=0,07) and the mean 
vertebrae trabeculae thickness decrease in KO mice (p=0,05). Taken together, these results 
signify lower bone volume in KO mice as compared to WT littermates. 
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Figure 17 Flk1:cre-PHD2f/f mice have reduced trabecular bone. (a) This is a 3D reconstruction of femoral 
trabecular bone of WT and KO 8-week-old mice. Peripheral quantitative computed tomography analysis of 
trabecular bone of femoral (b) and lumbar WT and KO male mice. Data was collected from three independent 
experiments n=6-10. Data is presented as Mean ± SD. Statistical significance was calculated using the Mann-
Whitney U test. 
 
This data indicates that endothelial PHD2 signaling reduced activity of both bone 
forming osteoblasts and bone resorbing osteoclasts witch resulted in decreased bone 
phenotype. 
 
4.1.3.2 Loss of PHD2 in endothelial cells leads to decrease of endothelial 
pericyte coverage 
 
Pericytes form a discontinuous layer in close contact with endothelial cells (Diaz-
Flores et al. 1991). They support endothelial function by regulating vessel diameter (Gerhardt 
& Semb 2007) as they maintain vessel integrity and permeability (Stallcup et al. 2016). It has 
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been previously shown that ablation of PHD2 from endothelial cells leads to increased 
pericyte recruitment on pulmonary endothelial cells (Dai et al. 2016; S. Wang et al. 2017). I 
therefore hypothesize that changed signaling in endothelial cells will also affect the pericyte 
coverage of the vasculature in bone marrow. I utilized immunofluorescent staining of the 
endothelial cell marker endomucin and the pericytes that are positive for the neural-glial 
antigen-2 surface marker (NG2). To determine the coverage of pericytes on endothelial cells, 
I have quantified the NG2+ cell signal within one cell length from endothelial cells (Fig. 18a) 
(Collinet et al. 2010). I then normalized the result by total endothelial area assayed. I have 
observed a decrease in the coverage of endothelial cells by pericytes in KO mice as opposed 
to WT littermates (Fig. 18b).  
	
Figure 18 Pericyte coverage of KO ECs in the BM is decreased. (a) Strategy of quantification of pericyte 
signal. 10um bone marrow sections were stained with DAPI (white), endomucin (magenta A594) and NG2 (green 
A488). The area within one cell width from endomucin is marked with a yellow line. All the signal within the 
masked area was quantified and normalized to the total area surveyed (b). Sections were quantified from 3 WT vs 
3 KO mice with 15 images per mouse. Data is presented as Mean ± SD. Statistical significance was determined 
using the Mann-Whitney U test. The scale bar represents 10µm. 
 
Together these data indicate that PHD2-induced signaling in the endothelial cell, 
decrease a selection of cell lineages from the BM niche.  
 
4.1.4 Loss of PHD2 in endothelial cells leads to alterations of hematopoietic 
cells in the periphery 
	
 
To assess changes to the hematopoietic compartment, I first examined the mature 
hematopoietic stem cells in the periphery. Peripheral blood consists of erythrocytes, 
thrombocytes, leukocytes and plasma (Fig. 19). Leukocytes together with platelets make up 
about 1-2% of the total blood volume while erythrocytes occupy the remaining 40-45%. The 
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rest of blood volume is occupied by plasma. I characterized changes in the peripheral blood 
with a hematology analyzer that assesses blood based on electrical impendence, flow 
cytometry and fluorescence flow cytometry.  
	
Figure 19 Components of the peripheral blood. The cellular components of the peripheral blood consist of 
three cell groups: enucleated erythrocytes and platelets and nuclei containing leukocytes. Leukocytes, also 
known as white blood cells can be further divided into neutrophils, lymphocytes, monocytes, eosinophils and 
basophils. 
	
4.1.4.1 Erythrocyte and platelet numbers are significantly decreased in KO 
mice 
 
Erythrocytes, also known as red blood cells (RBC), occupy 40-45% of the total blood 
volume – this percentage is referred to as the hematocrit (HCT). Functionally, RBCs are 
responsible for the transport of O2 and CO2, which is possible by high levels of the iron-
containing respiratory molecule - hemoglobin (HGB). RBC number, HCT and HGB are used 
to describe the erythrocyte fraction of the blood. I observed a minimal but significant 
decrease in RBC number in KO mice (Fig 20a). While initially intriguing, this represents a 
normal physiological variance. No changes were observed in HGB and HCT levels between 
KO and WT littermates (Fig 20b and 20c).  
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Figure 20 KO mice display slight reduction of RBC number. This graphical representation shows red blood 
cell (RBC) number (a), hemoglobin (HGB) concentration (b) and hematocrit (HCT) (c) changes between KO and 
WT mice. Representative data for one out of 7 experiments n=13-14. Data is presented as Mean ± SD. Statistical 
significance was determined using the  Mann-Whitney test, 
 
Mature RBCs are further characterized on the basis of their size and hemoglobin 
content. Mean corpuscular volume (MCV) is defined as the average volume of single RBC 
while mean corpuscular hemoglobin (MCH) indicates the average concentration of 
hemoglobin in the RBC. Mean corpuscular hemoglobin concentration (MCHC) is defined as 
the average concentration of HGB in consideration with RBC size. To assess whether 
erythroblast characteristics of RBC have changed, I used the hematology analyzer (Fig 21). 
The RBC analysis revealed a significant increase in size (Fig 21a) and consequently an 
increase of hemoglobin content of KO mice in comparison to WT littermates (Fig 21b). Since 
this increase is proportional, the normalized hemoglobin content per one red blood cell 
remained unchanged (Fig. 21c). This condition is referred to as macrocytosis and is not 
always considered as pathologic condition.  
	
Figure 21 Average size and hemoglobin content is increased in KO mice. Hematology analysis of 
erythrocyte characteristics: mean corpuscular volume (MCV) (a), mean corpuscular hemoglobin (MCH) and mean 
corpuscular hemoglobin concentration (MCHC). The representative data for one out of 7 experiments n=13-14. 
Data is presented as Mean ± SD. Statistical significance was calculated using the Mann-Whitney U test. 
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Another enucleated peripheral blood component is thrombocytes also known as platelets. 
Platelets assure hemostasis by aggregating to damaged endothelium and promoting the 
coagulation cascade to form a blood clot, ultimately stopping the bleeding. A pathological 
decrease in platelet number of 60% or more is known as thrombocytopenia and may result in 
internal and external bleeding (Gauer et al. 2012). Interestingly, I observed a drop in platelet 
number in KO mice compared to WT littermates (Fig. 22). Although significant (P=0.008) this 
mild decrease is not yet considered pathological (Gauer et al. 2012).  
	
Figure 22 KO mice display slightly decreased platelet number in peripheral blood. The hematology analysis 
of the platelet (PLT) number in peripheral blood. The representative data is for one out of 7 experiments n=13-14. 
Data is presented as Mean ± SD. Statistical significance was calculated using the Mann-Whitney U test. 
	
4.1.5 Significant increase of white blood cells in the periphery upon loss of 
endothelial PHD2  
 
Leukocytes, also known as white blood cells (WBC), are a heterogeneous population 
of cells that can be further divided into myeloid and lymphoid cells. Strikingly, I observed a 
significant increase in the WBC compartment in KO mice as compared to WT littermates 
(Fig. 23).  
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Figure 23 Flk1:cre-PHD2f/f knockout mice have significantly increased white blood cells in their peripheral 
blood. The hematology analysis of the white blood cell (WBC) number in peripheral blood. Representative data 
for one out of 7 experiments n=13-14. Data is presented as Mean ± SD. Statistical significance was calculated 
using the Mann-Whitney U test. 
 
Surprisingly, I observed a significant increase in neutrophils (Fig. 24a) and an even 
more pronounced increase in monocytes in the peripheral blood of KO mice (Fig. 24b).  This 
result suggests increased production of white blood cells by hematopoietic progenitors.  
	
Figure 24 Prominent increases of neutrophil and monocytes in peripheral blood. The hematology analysis 
of the neutrophil and monocyte number in peripheral blood. The representative data for one out of 7 experiments 
n=13-14. Data is presented as Mean ± SD, Statistical significance was calculated using the Mann-Whitney U test, 
 
Lastly, I observed a significant increase in lymphocytes of the KO peripheral blood 
(Fig. 25). 
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Figure 25 Pronounced lymphocyte increase in periphery. The hematology analysis of the lymphocyte number 
in peripheral blood. The representative data for one out of 7 experiments n=13-14. Data is presented as Mean ± 
SD. Statistical significance was calculated using the Mann-Whitney U test.  
 
The presented data clearly demonstrate a significant increase in most leukocytes in 
the peripheral blood with a simultaneous mild decrease in thrombocytes and erythrocytes. To 
determine the mechanism of observed changes in all compartments, I sought to determine 
which hematopoietic stem and progenitor activity has been augmented.  
 
 
4.1.6 Loss of endothelial PHD2 does not impact the hematopoietic stem cells 
in the bone marrow.  
 
Blood cell production (hematopoiesis) occurs primarily in the bone marrow of adult 
organisms. However, upon a wide range of hematopoietic stresses that include anemia 
(Bennett et al. 1968; Cheshier et al. 2007) or myeloablation (Morrison et al. 1997), 
hematopoiesis occurs outside bone marrow, referred to here as extramedullary organs such 
as the spleen. Extramedullary hematopoiesis in the spleen occurs predominantly near the 
sinusoidal endothelium of splenic tissue known as red pulp (Kiel et al. 2005). In this region, 
factors such as CXCL12 and SCF are highly enriched (Ding et al. 2012). Because I observed 
significant changes in the blood cell content of PHD2 KO mice, I hypothesize that augmented 
signaling in the endothelium results in an increase of hematopoietic stem and progenitor 
cells. This impact likely extends to both primary and extramedullary sites of hematopoiesis in 
these KO mice.  
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4.1.6.1 The frequency of HSCs as well as their activity in bone marrow are 
unchanged upon loss of PHD2 in endothelial cells 
 
The observed increase of white blood cells in the periphery is likely a result of 
changed hematopoietic stem cell activity in bone marrow. Ample evidence shows that 
endothelial cells maintain stem cell activity (Butler et al. 2010; Ding et al. 2012). Self-
renewing stem cells with a multipotent capacity are referred to as LSK cells (Fig. 26a) 
(Spangrude et al. 1988). The LSK compartment is a heterogeneous population of cells with 
differing self-renewal and proliferative capabilities, yet all are capable of generating all 
lineages (Morrison et al. 1995). To further separate these cells into populations according to 
their repopulating ability, additional surface markers are used (described in detail in material 
and methods) (Fig. 26b) (Oguro et al. 2013).  
	
Figure 26 Schematic representation of FACS gating of LSK cells and HSC, MPP2, MPP3/4 population 
constituting this heterogeneous population. Representative FACS plots of a WT gating of most 
undifferentiated hematopoietic stem cells (HSC). Self-renewing hematopoietic stem cells can be characterized by 
absence of mature lineage surface marks and presence of cKit and Sca1 surface markers (a). This 
heterogeneous population can then be further distinguished by differential expression of two surface markers 
CD48 and CD150 (b). True HSC show high expression of CD150 and low expression of CD48 (LSK, CD48-
CD150+). Multipotent progenitor cells 2 (MPP2) have high expression of both CD48 and CD150 (LSK, 
CD48+CD150+). Lastly, the MPP3/4 express high levels of CD48 and low levels of CD150 (LSK, CD48+CD150-). 
 
Fluorescence flow cytometry analysis of the LSK compartment revealed no significant 
difference in frequency or in the absolute number of the stem cell population (LSK) between 
KO and WT littermates (Fig. 27a). To further investigate the differences between 
subpopulations in the heterogeneous LSK cells, I focused on hematopoietic stem cells 
(HSCs) and the multipotent progenitors (MPP2 and MPP3/4) (Fig. 27b).  Analysis revealed 
that both the frequency and the absolute numbers of all three cell populations in KO and WT 
littermates were unchanged (Fig. 27b). This data indicate that changes in endothelial 
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signaling following PHD2 inactivation does not cause an effect to the most undifferentiated 
stem cell compartment in bone marrow.  
	
Figure 27 Frequency and absolute cell numbers of LSK cells and subsequent three populations 
constituting LSK cells in the bone marrow. FACS results showing frequency (upper graphs) and absolute cell 
numbers of each HSC, MPP2 and MPP3/4 cells. Data was pulled from two independent experiments. n=11. The 
Data is presented as Mean ± SD, Statistical significance was calculated using the Mann-Whitney U test, 
 
A frequency and cell number analysis of the stem cell compartment does not provide 
information on altered activity. Self-renewal and differentiation of stem cells are 
fundamentally associated with the cell-cycle progression. Studies on mouse pluripotent stem 
cells have shown that differentiation is characterized by a lengthening of the G1 phase of the 
cell cycle (Calder et al. 2012). I hypothesize that endothelial signaling influenced 
hematopoietic stem cell cycling.  
The cell cycle consists of four distinct phases G1, S, G2, and M. During the G1 
phase, the cell increases in size and prepares for DNA synthesis. The S phase marks DNA 
replication. During the G2 phase, the cell continues to grow while ensuring that all 
components are prepared for the final stage of division. Next, the M phase marks the 
inhibition of cell growth and the cell division into two daughter cells. A final phase is G0 – the 
resting stage, where a cell has left the cell cycle and has stopped dividing. A commonly used 
marker for cell cycle is the ki-67 protein, which is strictly associated with the nuclei of 
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proliferating cells in G1, S, G2, M (Gerdes et al. 1991). Therefore, with FACS one can 
distinguish between different stages of cell cycle by combining the nuclear dye (DNA 
content) and an anti-ki67 antibody. This analysis provides a snapshot of the cell cycle status 
among 3 groups: 
• G0 resting stage (ki67 low,(2n));  
• G1 phase (ki67 high,(2n));  
• S/G2/M phase (ki67 high, (2n~4n)) (Fig. 28a).  
	
To test whether the increase in mature hematopoietic cells in the periphery is a result 
of increased cycling of HSCs, I used FACS surface staining analysis of each population of 
the LSK cell cycle. I observed no differences in the most quiescent HSC and more 
proliferating MPP2s between WT and KO littermates (Fig. 28b and c). Remarkably, I have 
noticed a significant decrease in the frequency of quiescent MPP3/4 (Fig. 28d). This result 
was supplemented by an increase, although not significant, in frequency of MPP3/4 cells in 
the G1 phase (p=0,06). The data suggests that the most proliferative yet still undifferentiated 
multipotent progenitors entered the cell cycle upon changes in the endothelial cell PHD2 
oxygen sensor associated signaling in bone marrow.  
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Figure 28 Frequency of cell cycle status of each of the undifferentiated progenitors of the LSK population. 
(a) Representative FACS plots of MPP3/4 population of WT and KO mice. (b-d) Graphs of three cell cycle stages 
G0, G1, SG2M analyzed for each constituent of LSK cell populations: HSC (b), MPP2 (c) and MPP3/4 (d). Data 
was obtained from two independent experiments n=11-9. Data is presented as Mean ± SD, Statistical significance 
was calculated using the Mann-Whitney U test, 
 
4.1.7 Loss of PHD2 leads to increase in hematopoietic stem cells in the spleen 
	
Under a wide range of hematopoietic stresses that include anemia (Bennett et al. 
1968; Cheshier et al. 2007), hematopoiesis mobilizes to the extramedullary tissues such as  
the spleen. I hypothesize that gene expression changes on the endothelial cells upon PHD2 
ablation direct HSPC relocation to the spleen. To assess the direct changes to the 
hematopoietic compartment of the spleen, I utilized FACS analysis and the same set of 
membrane surface markers as in bone marrow (Fig. 26).  
First, I assessed the LSK compartment and observed no differences in frequency and 
numbers of these heterogeneous populations (Fig. 29a). Interestingly, a detailed analysis of 
each population that constitutes LSK cells leads to an observation of a significant increase in 
the frequency of HSCs in the spleen of KO mouse. However, this was not reflected in the 
change of their absolute numbers (Fig. 29b). Due to the very low frequency of HSC in the 
spleen (Fig. 29b), only an extraordinary increase would be reflected in the total cell numbers 
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(Fig. 29b), as total cellularity of spleen is relatively high (Fig. 29e). In contrast, no other 
population of self-renewing multipotent progenitors cells MPP2 (Fig. 29c) or MPP3/4 (Fig 
29d) was altered in KO mice relative to WT littermates. This result implies that signaling 
induced by endothelium led to an increase in HSC frequency in the spleen.  
	
Figure 29 Frequency and absolute cell numbers of LSK cells and subsequent populations in the spleen. 
FACS results of frequency (upper graphs), absolute cell numbers of each LSK (a), HSC (b), MPP2 (c), MPP3/4 
(d) and total cell numbers in the spleen (e). The data pulled from three independent experiments. n=15-13. Data 
is presented as Mean ± SD, Statistical significance was calculated using the Mann-Whitney U test, 
 
Although I observed significantly increased HSC frequency in the spleen, the cell 
number remained the same. Therefore, I concluded that this change is not responsible for a 
substantial increase of WBC number in the periphery. Because the analysis of the 
hematopoietic stem cell compartment in the bone marrow and the spleen did not reveal 
possible mechanisms of WBC increase, I turned to lineage-committed progenitors to 
determine the mechanism of the observed phenotype in the periphery.  
 
4.1.8 Loss of endothelial PHD2 impacts lineage-committed progenitors in 
bone marrow and the spleen 
 
4.1.8.1 Loss of PHD2 in endothelial cells does not change frequency or 
numbers of lineage committed progenitors in bone marrow and the 
spleen 
 
The peripheral blood of KO mice had slightly decreased platelet numbers (Fig. 30a). 
Megakaryocyte progenitors (MkP) give rise to the large, multinucleated megakaryocytes. The 
function of these cells is platelet production. Interestingly, mature megakaryocytes replicate 
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their DNA without dividing, which results in the development of a large polyploid cell that can 
have up to 64N in humans and 256N in mouse (Deutsch & Tomer 2006). The enlarged cell 
then buds off platelets and releases them into the periphery. Thrombocytes, therefore, are 
fragments of cytoplasm enclosed in and derived from megakaryocyte plasma membrane. 
Their primary function is to assure clotting of the blood in response to signaling from injured 
or inflamed vasculature, supported by their association and dependence on this system 
(Malara et al. 2015; Rafii et al. 1995). Moreover, megakaryocytes are dependent on the 
endothelial cell-cell interaction and signaling molecules (Avraham et al. 1993). These data 
led me to the hypothesis that PHD2 oxygen sensor associated signaling influenced 
megakaryocytes.  
To assess whether altered endothelial cell signaling impacts megakaryocyte 
progenitors in the bone marrow and the spleen, I examined the progenitors of 
megakaryocytes. FACS analysis revealed no changes in the frequencies and absolute 
numbers of bone marrow megakaryocyte progenitors (Fig. 30b). Next, I determined whether 
any changes in their differentiation potential could be resolved by cell cycle analysis.  No 
differences between frequencies in each cycle stage of megakaryocyte progenitors between 
the WT and KO littermates were observed (Fig 30c). Therefore, it is likely that the differences 
in platelet numbers in the periphery depend on the changes of the number or function of 
megakaryocytes. To test this idea, I determined if numbers of mature megakaryocytes in WT 
and KO littermates were changed. Bone marrow sections were stained with CD41 – a 
megakaryocyte specific marker and nuclear marker DAPI identifying the multinuclear 
character of megakaryocyte. Quantification of the megakaryocytes number revealed no 
change between WT and KO littermates (Fig. 30d).  
 
	
Figure 30 Platelet decrease is not due to changes in frequency or activity of megakaryocyte progenitors 
in bone marrow. (a) Analysis of hematology analyzer of platelet numbers in peripheral blood. Representative 
data is for one out of 7 experiments n=13-14. (b) FACS analysis of megakaryocyte progenitors (MkP) in bone 
marrow. Data pulled from two independent experiments n=11. (c) Analysis of cell cycle of MkP by FACS. 
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Representative data of one experiment n=6-5. (d) Quantitative image analysis of bone marrow sections stained 
for megakaryocytes. Data quantified from 3WT and 3KO mice, 15 images per each mouse assayed. Data for all 
depicted graphs are mean±SD, Statistical significance was calculated using the Mann-Whitney U test. 
 
To determine whether the decrease in the megakaryocyte progenitor could be 
explained by a decrease in splenic progenitors I assessed the spleen.  Similarly to results 
from bone marrow, analysis of spleen megakaryocyte progenitors, revealed no differences in 
frequency and absolute cell numbers between WT and KO littermates (Fig. 31).  
	
Figure 31 Analysis of the megakaryocyte progenitor (MkP) in the spleen revealed no difference between 
WT and KO littermates.  FACS analysis of megakaryocyte progenitors (MkP) in the spleen. Data pulled from 
three independent experiments n=15-13. Data for all depicted graphs are mean±SD, Statistical significance was 
calculated using the Mann-Whitney U test, 
  
Therefore, I concluded from the analysis of megakaryocytes and their progenitors that 
the minimal differences in thrombocyte numbers cannot be explained by a decrease in the 
frequency and numbers of platelet progenitors.   
 
4.1.8.2 Decrease in RBCs is resulting from a decrease in splenic erythrocyte 
progenitors 
 
Peripheral blood revealed minimal but significant decreases in RBC content but not in 
HGB or HCT (Fig. 20).  
Erythrocytes represent the most common cell type in blood with a long average life 
span of 120 days in humans and ~45 days in mice. Erythroid progenitors undergo an 
enormous expansion to fulfill the requirement of ~2 x 1011 cells per day. The erythroid 
differentiation process can be categorized into cells belonging to three classes based on their 
activity: progenitors, precursors and red blood cells (Fig. 32). Bipotent megakaryoctye-
erythrocyte progenitors (preMegE) differentiate into erythroid lineage specific burst forming 
unit-erythroid (preCFUe) that further differentiates into a colony forming unit (CFU-e) (Fig. 
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34) (Gregory & Eaves 1978). The modulation of a progenitor cell amplification is thought to 
play a major role in a change of erythroid output in response to tissue hypoxia (Broudy et al. 
1996). These progenitors are known to be located in bone marrow in their own unique niches 
called the erythoblastic islands, within proximity of the CD169+ macrophages first described 
by Bessis et al. Even though several factors are known to regulate erythropoiesis, 
erythropoietin (EPO) has been known to be the main cytokine driving RBC proliferation, 
differentiation and survival (Koury & Bondurant 1990). I hypothesize that endothelial cells will 
impact primarily erythroid linage progenitors in the bone marrow leading to a minimal drop of 
RBC number in periphery. 
	
Figure 32 Erythrocyte differentiation transitory progenitor pathway. Hematopoietic stem cell (HSC) gives 
rise to the common myeloid progenitor (CMP). This multipotent progenitor then differentiates into pre-
megakaryocyte/erythrocyte progenitor (preMegE) of dual lineage commitment. The next progenitor is pre-colony 
forming unite erythrocyte (preCFUe) progenitor that gives rise to colony formin units – erythrocyte (CFU-e). CFU-
e’s then give rise to the first of the erythrocyte precursors – the proerythroblast. Proerythroblasts through mitotic 
division differentiate into basophilic erythroblast, that divides into a polychromatic erythroblasts, which finally 
divides into a ortochromatic erythroblasts. At this stage ortochromatic erythroblasts releases its nuclei, becoming 
reticulocyte. Reticulocytes circulate in periphery until their final maturation into RBC. 
	
4.1.8.3 Loss of endothelial PHD2 does not influence erythroblast progenitors 
in bone marrow or the spleen 
	
To determine the changes of frequency and number of erythrocyte specific 
progenitors in the bone marrow, I used FACS. I first assessed the common progenitor for 
megakaryocytes and erythrocytes – preMegE but detected no difference between WT and 
KO littermates in both the frequency and total cell numbers (Fig 33a). Next, analysis of 
erythroid specific CFUe and preCFUe progenitors revealed no alterations between WT and 
KO frequency and cell numbers in the bone marrow (Fig. 33b).  
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Figure 33 Erythroid lineage committed progenitors in bone marrow are unchanged.  FACS analysis of pre 
megakaryocyte/erythroid progenitors (a) and pre colony forming units and colony forming units (b) in bone 
marrow. Data pulled from two independent experiments n=11. . Data for all depicted graphs are mean±SD, 
Statistical significance was calculated using the Mann-Whitney U test, 
 
To determine whether the activity of CFUe and preCFUe progenitors in the bone 
marrow could reveal the mechanism of erythroblast drop, I established their cell cycle using 
FACS. Interestingly, I observed a significant decrease in frequency of quiescent preCFUs 
(Fig. 34b) and a consequent tendency of an increase in the G1 phase preCFUe (WT 
mean=59,4 vs KO men=64,9; p=0,175) (Fig. 34b). No other change was observed in the 
frequencies in cycling of the erythroid progenitors between WT and KO littermates. (Fig 34a, 
34c). This surprising effect does not support the observed decrease of RBC in peripheral 
blood (Fig. 20). Rather, it would suggest an increase in mature erythrocytes and not their 
decrease.  
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Figure 34 Cell cycle of bone marrow erythroid progenitors. Analysis of cell cycle of preMegE (a) preCFUe (b) 
and CFUe (c) analysed by FACS. Representative data of one experiment n=6-5. Data for all depicted graphs are 
mean±SD, Statistical significance was calculated using the Mann-Whitney U test, 
 
Consequently, I hypothesize that the minimal decrease in mature erythrocytes is a 
result of a decreased progenitors in the spleen. Similarly, analysis of splenic preMegE, 
preCFU and CFUe progenitors frequencies and absolute numbers did not reveal any 
significant differences. (Fig. 35a, b, c) 
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Figure 35 Erythroid lineage committed progenitors in spleen are unchanged.  FACS analysis of pre 
megakaryocyte/erytrhroid progenitors (preMegE) (a), pre colony forming units (preCFUe) (b) and colony forming 
units (CFUe) (c) in the spleen. Data pulled from three independent experiments n=14-13. Data for all depicted 
graphs are mean±SD, Statistical significance was calculated using the Mann-Whitney U test, 
 
 This data indicates that erythroblast progenitors in the bone marrow and the spleen 
are unchanged by signaling changes resulting from endothelial PHD2 inactivation. To 
determine the mechanism of the observed phenotype I turned to assess erythroblast 
precursors. 
4.1.8.4 Loss of PHD2 in endothelial cells impact erythrocyte precursors 
specifically in the spleen but not in the bone marrow 
	
CFU-e progenitors subsequently give rise to erythroblasts – morphologically 
distinguished precursors. Interestingly, each erythroblast is produced by successive mitosis. 
Precursor differentiation starts with a proerythroblast. Proerythroblast, then gives rise to 
basophilic erythroblast, then polychromatic erythroblast and finally ending with 
orthochromatic erythroblast (Fig. 32). Each mitotic division is characterized by a progressive 
series of: (Yoshihara et al. 2007) 
• erythroblast expansion 
• accumulation  of hemoglobin 
• decrease in cell size 
• nuclear pyknosis 
• decrease in RNA content.  
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The last orthochromatic erythroblast expels the residual nuclei and ultimately becomes 
reticulocyte (K. Chen et al. 2009). Thus, I hypothesized that altered endothelial signaling 
impacts the activity and speed of division of erythroid precursors. I utilized FACS to 
differentiate between each population of erythroblasts, exploiting the relationship between 
erythroblast size and expression levels of erythroid specific surface markers Ter119, CD44 
(K. Chen et al. 2009) (Fig. 36).  
	
Figure 36 Graphical representation of erythroblast populations in bone marrow of a WT mouse. 
Erythroblast classification based on differential expression of CD44 and size. Proerythroblasts are characterized 
as the cells with the highest expression of CD44 surface marker with simultaneous expression of Ter119 
(population I) (a). To distinguish further erythroblast differential expression of CD44 and size (b) is analyzed. 
Basophilic erythroblasts (population II) are the biggest cells with very high expression of CD44. Polichromatic 
erythroblasts are smaller with medium expression of CD44 (population III). Ortochromatic progenitors are small 
cells with low expression of CD44 (population IV). Finally, reticulocytes are small cells as indicated by low FSC 
and no expression of CD44 (population V) 
 
Analysis of erythroblast progenitors in bone marrow did not reveal any difference 
between frequencies of erythroblast populations of WT and KO littermates. (Fig. 37) This 
result indicates that erythroblast division and differentiation in bone marrow is unchanged 
upon endothelial PHD2 inactivation, signaling changes during steady state.  
	
Figure 37 No change between WT and KO mice observed in bone marrow erythroblast populations. FACS 
analysis of all erythroblast populations from bone marrow: proerythroblasts, basophilic erythroblasts, 
polychromatic erythroblasts, ortochromatic erythroblasts, reticulocytes/RBC.  Data pulled from two independent 
experiments n=11-9. Data for all depicted graphs are mean±SD, Statistical significance was calculated using the 
Mann-Whitney U test 
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Therefore, I hypothesize that splenic erythroblast differentiation contribute to the 
observed decreased RBC phenotype. Again, I employed FACS analysis of erythroblast 
progenitors based on the differential expression of Ter119 and CD44 combined with 
measurement of the cell size (Fig. 36). Evaluation of erythroblast precursors revealed a 
decrease in basophilic erythroblasts and subsequent decrease in polychromatic erythroblasts 
(Fig. 38).  
	
Figure 38 Significant decrease in basophilic and polychromatic populations of erythroblast precursors in 
the spleen. FACS analysis of all erythroblast populations from spleen: proerythroblasts, basophilic erythroblasts, 
polychromatic erythroblasts, ortochromatic erythroblasts, reticulocytes/RBC.  Data pulled from two independent 
experiments n=11-9. Data for all depicted graphs are mean±SD, Statistical significance was calculated using the 
Mann-Whitney U test 
  
The contribution of splenic erythropoiesis is very low at steady state. Moreover, the 
observed erythroblast precursor decrease leads to marginal decrease of RBC number in 
periphery. Therefore, these results could potentially explain the observed minimal decrease 
of RBC from periphery.  
 
 
4.1.9 Loss of PHD2 in endothelial cells leads to an increase in frequency and 
activity of myeloid progenitors in bone marrow and the spleen 
 
The nucleated myeloid compartment consists of monocytes, neutrophils, basophile 
and eosinophil cells. Since basophiles and eosinophils in homeostatic conditions are in low 
numbers in blood circulation, I did not observe any differences between WT and KO 
littermates (data not shown). The majority of myeloid nucleated cells are the neutrophils and 
monocytes. Endothelial PHD2 knockout mice present a high increase of both monocytes as 
well as neutrophils (Fig. 39a). First, lineage committed progenitors that can be defined based 
on the expression of surface markers is the pre granulo-maegakaryocyte (pre-GM) 
progenitor. I have therefore assessed the amount of preGM in bone marrow. I utilized FACS 
analysis to determine the frequency and total numbers of preGM on the basis of surface 
markers. I found a significant increase in the frequency of preGM but no increase in absolute 
cell numbers in the bone marrow in KO mice relative to WT littermates (Fig. 39b).  
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Figure 39 Monocyte and neutrophil increase in periphery is due to changes in frequency of preGM 
progenitors in the bone marrow. (a) Analysis of monocyte and neutrophil numbers from peripheral blood by 
hematology analyzer. Representative data for one of the 7 experiments n=13-14 (b) FACS analysis of 
pregranulocyte macrophage progenitors (preGM) in bone marrow. Data pulled together from two independent 
experiments n=15-13. Data for all depicted graphs are mean±SD, Statistical significance was calculated using the 
Mann-Whitney U test. 
 
Subsequently, I determined the activity of preGM by analyzing the cell cycle. 
Interestingly, I determined an increase in the frequency of cells in the G1 phase of the cell 
cycle. Remarkably, I also observed a slight decrease (p=0,08) in cells actively progressing 
through the cell cycle (S-G2-M) in comparison to WT littermates (Fig. 40).  
 
	
Figure 40 Monocyte and neutrophil increase is due to changes in frequency and activity of preGM 
progenitors in bone marrow. (a) Analysis of hematology analyzer of monocyte and neutrophil numbers in 
peripheral blood. Representative data for one out of 7 experiments n=13-14. (b) FACS analysis of pre granulocyte 
macrophage progenitors (preGM) in bone marrow. Data pulled together from two independent experiments n=15-
13. (c) Analysis of cell cycle of preGM by FACS. Representative data of one experiment n=6-5. Data for all 
depicted graphs are mean±SD, Statistical significance was calculated using the Mann-Whitney U test, 
 
Alterations in endothelial cell signaling upon PHD2 induced changes might induce an 
extramedullary response. Therefore, I hypothesize that splenic myeloid progenitors will, 
similarly to bone marrow progenitors, be affected. I analyzed using FACS myeloid progenitor 
differences between WT and KO littermates. Interestingly, I observed similarly to bone 
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marrow, a ~60% increase in the frequency of splenic preGM (Fig 41). Total cellularity was 
not different between WT and KO littermates.   
	
Figure 41 Monocyte and neutrophil increase is due to changes in frequency of preGM progenitors in 
spleen. FACS analysis of pre granulocyte macrophage progenitors (preGM) in the spleen. Data pulled from three 
independent experiments n=15-13. Data for all depicted graphs are mean±SD, Statistical significance was 
calculated using the Mann-Whitney U test, 
 
These results indicate that the loss of endothelial PHD2 results in an increased 
frequency of committed myeloid progenitors in bone marrow as well as spleen.  
 
4.1.10 Loss of endothelial PHD2 impacts lymphocyte progenitors in secondary 
lymphatic organs but not in the bone marrow 
 
B and T cells diverge from a common lymphoid progenitor (CLP) that is restricted to 
all cell types of lymphoid lineage. CLP is a distinct progenitor classified by the absence of 
mature lineage markers (Lin-), low expression of Sca1 and cKit (cKitlow, Sca1low), and high 
expression of Fms-related tyrosine kinase 3 (Flt3+ or CD135+) and IL-7Ra (CD127+) 
(Karsunky et al. 2008). Similar to HSCs, the development of the lymphocyte progenitors 
requires a specific microenvironment. Therefore, I hypothesize that altered endothelial cell 
signaling will influence the common lymphocyte progenitor in bone marrow. I turned to FACS 
to determine changes in the CLPs between WT and KO littermates. However, I have not 
observed statistically significant (p=0,09) differences in the frequencies or absolute cell 
numbers of CLP in bone marrow (Fig. 42). 
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Figure 42 Common lymphocyte progenitor frequency and absolute cell number is not changed in bone 
marrow. FACS analysis of CLP in bone marrow. Data pulled from two independent experiments n=7-9. Data for 
all depicted graphs are mean±SD, Statistical significance was calculated using the Mann-Whitney U test, 
 
Both B and T cell precursors are generated in bone marrow but then egress into 
peripheral blood to reach the secondary lymphoid organs. CLP is the last progenitor common 
for T and B cells after which stage they diverge in the development process. T cell 
progenitors migrate into the thymus where they undergo negative selection (Kaye 2000) 
whereas B cells undergo rearrangement of the immunoglobulin H and L chain gene loci 
surface expression of the B cell antigen receptor in bone marrow. Immature B cells then 
migrate from bone marrow to the spleen (Allman & Pillai 2008; Osmond 1986) where they 
undergo further maturation via transitional stages progenitors leading to differentiation into 
follicular (FO) and marginal zone (MZ) B cells (Dammers et al. 1999; Vitetta et al. 1975). 
Here, lymphocytes are closely associated with microvasculature of the spleen that essentially 
separates splenic tissue into different splenic zones – red pulp and white pulp (Snook 1964). 
Since I observed a prominent increase in lymphocytes in the periphery, I hypothesize that the 
homing of immature B cells is perturbed due to the changes in endothelial signaling.  
Immature B cell progenitors are recognized as recent immigrants to the bone by their 
high expression levels of heat stable antigen (CD24/HAS) and the presence of AA4 antigen 
(AA4.1)(Allman et al. 1992). These initial transitory progenitors (T1) are often times referred 
to as newly formed B cells. T1 progenitors then differentiate into T2 “transitional B cells” 
(Cariappa & Pillai 2002) (Fig. 43a). Using FACS and taking advantage of differential 
expression of surface markers between the transitory progenitors, I have assessed the T1 
and T2 progenitors presence in the spleen (Fig. 43b). I observed no differences in frequency 
or absolute numbers of transitory progenitors between WT and KO littermates (Fig. 43b). 
This indicates no changes in homing of immature B cells into the spleen.  
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Figure 43 Schematic and graphical representation of transitory progenitors of B cells in the spleen. (a) 
Schematic of differentiation of transitory progenitors T1 into T2 progenitors. T2 progenitors then can differentiate 
into Folicular cells or marginal zone progenitors (MZP) and ultimately into marginal zone B cells. (b) FACS 
analysis of T1 and T2 transitory progenitors in the spleen. Representative data of one of two experiments n=4. 
The data for all depicted graphs are mean±SD. Statistical significance was calculated using the Mann-Whitney U 
test. 
	
The transitional progenitors subsequently give rise to both folicullar B cells and 
marginal zone progenitors (MZP) that ultimately differentiate into marginal zone B cells (Fig. 
43). The lineage specific progenitors have been shown to be dependent on signaling from 
the microenvironment (Cariappa et al. 2000; Girkontaite et al. 2001; Guinamard et al. 2000). 
Specifically marginal zone B cells generation and maintenance is dependent on Notch 
signaling (Martin & Kearney 2002). Since Notch signaling on PHD2 lacking endothelial cell 
was previously shown to be increased (S. Wang et al. 2017), I hypothesize that marginal 
zone progenitors will be affected in the spleen of KO mice. I used FACS analysis based on 
the differences in expression of surface markers to determine differences in the frequency 
and total cell numbers of the KO and WT littermates. I have observed a decrease in the 
marginal zone progenitors frequency and a similar decrease in their total cell number (Fig. 
44). This indicates impairment in the differentiation of the marginal zone B cells but certainly 
does not explain the observed phenotype of increased lymphocyte numbers in the periphery.  
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Figure 44 KO mice show decreased frequency and absolute marginal zone progenitor numbers. Graphs 
depicting FACS analyzed frequency and total cell numbers of marginal zone progenitors (MZP) in the spleen. 
Representative data of one of two experiments n=4. Data for all depicted graphs are mean±SD. Statistical 
significance was calculated using the Mann-Whitney U test. 
 
Follicular cells in the secondary lymphatic organs are participating in T-cell dependent 
immune responses to protein antigens. They circulate through the periphery and the bone 
marrow ultimately aggregating around endothelial cells and respond into T cell independent 
manner to blood borne pathogens (Cariappa et al. 2005; Cariappa et al. 2007).. In contrast, 
marginal zone B cells are stationary, residing only in the marginal zone of the spleen. Here, 
they initiate low affinity antibody production before follicular start producing high affinity 
antibodies (Allman & Pillai 2008).  
Marginal zone B cells and follicular B cells constitute anatomically distinct mature B 
cell subsets in the spleen. They can be distinguished by the differential expression of IgM, 
IgD, CD23 and CD21 expressed on their membrane. Marginal zone B cells are characterized 
by the high expression levels of IgM and CD21, and at the same time, they express very low 
levels of IgD and CD23. In contrast, follicular cells express high levels of IgM, IgD and CD23 
while the expression of CD21 is intermediate (Oliver et al. 1997). I hypothesize that a 
decrease in marginal zone progenitors will result in a decrease of the mature marginal zone 
B cells in the spleen. To assess this, I have analyzed the spleen marginal and follicular cells 
using FACS. Indeed I observed a prominent drop in the frequency of the KO marginal zone B 
cells relative to the WT littermates (Fig. 45a). This result was supported by a decrease in the 
MZ total cell number (Fig. 45a). In contrast, follicular (FO) B cell frequency remained 
unchanged between WT and KO mice although I did observe a decrease in the total follicular 
cell numbers.  
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Figure 45 KO mice have pronounced decrease in  frequency and absolute marginal zone B cell numbers. 
FACS analysis of frequency and total cell numbers of marginal zone B cells (MZ) (a) and follicular B cells (FO) (b) 
in the spleen. Data pulled together from three experiments n=13-14. Data for all depicted graphs are mean±SD, 
Statistical significance was calculated using the Mann-Whitney U test. 
 
These results indicate that the PHD2 endothelial cell specific signaling is detrimental 
for the differentiation and maintenance of marginal zone B cells. Further study is required to 
determine the molecular mechanisms and effector molecules responsible for such a 
profound phenotype.  
 
4.2 Defining the impact of radiation exposure on the recovery of PHD2-
deficient endothelial cells and its hematopoietic compartment. 
4.2.1 Characterization of the non-lethal ionizing radiation damage to bone 
marrow endothelial and hematopoietic recovery  
 
Chemotherapy and radiation therapy are common therapies against cancer. It has 
long been known that chemo and radiotherapy induce apoptosis of the hematopoietic 
compartment as well as they induce the damage of endothelial cells (Shirota & Tavassoli 
1992). Remarkably, endothelial cell recovery has been shown to be instrumental for 
hematopoietic homeostasis (Avecilla et al. 2004; Rafii et al. 2003). Importantly, hypoxic 
signaling has been shown to accelerate endothelial recovery on ischemic injury (Kerkelä et 
al. 2013; Lee et al. 2015). Thus, I hypothesize that the loss of PHD2 in endothelial cells will 
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lead to their accelerated recovery after radiation therapy. In turn, this will facilitate the 
recovery of the hematopoietic compartment.   
To determine the strength of myeloablation assaults, I have considered different 
types categorized by the degree of hematopoietic and endothelial injury. Moderate and 
severe vascular regression and hematopoietic myeloablation in BM is achieved by non-lethal 
(650rad) or lethal (950rad) irradiation respectively (Doan et al. 2013; Hooper et al. 2009). 
Exposures above 10Gy result in rapid death due to the detrimental effect on neurological and 
gastrointestinal cells. Exposures between 1 and 10Gy primarily affect the hematopoietic 
system (Goans 2010).  Lethal, high dose ionizing radiation leads to cell cycle arrest, 
apoptosis and ultimately, abolition of the entire hematopoietic stem and progenitor cells (Till 
& McCulloch 2010). Such high doses are usually used in therapy for the preparation of the 
healthy donor derived hematopoietic stem cells engraftment (Gyurkocza & Sandmaier 2014). 
Without the transplantation of non-irradiated hematopoietic stem cells, lethal radiation results 
in pancytopenia, leading to increased bleeding, infections and ultimately death. However, 
lower doses of radiation, referred to as non-lethal, renders the organism transiently 
immunosuppressed but eventually leads to the recovery of bone marrow function within an 
endogenous hematopoietic population (Goans 2010). I hypothesize that the best model to 
study endothelial cell assault in the context of hematopoietic recovery is non-lethal (5,6Gy) 
irradiation. This method allows me to observe the long time recovery of the endothelial cells 
without a need to introduce exogenous hematopoietic cells. 
 
4.2.2 Loss of PHD2 from endothelium impacts endothelial recovery after 
myeloablative assault 
 
4.2.2.1 Loss of PHD2 in endothelial cells impacts endothelial cell morphology 
post myeloablative assault 
	
When considering molecular and cellular effects (Corre et al. 2013)., the endothelial 
network is one on of the highly affected bone marrow residing cells. Known effects on the 
endothelium are micro-vessel collapse, increased permeabilisation, endothelial activation 
leading to ischemia or fibrosis though increase in hypoxia and inflammation (Corre et al. 
2013; Mao 2016). I hypothesize that the best time to observe differences in endothelial cell 
recovery will be at the 2-week time point, based upon the previous studies investigating 
effects of the ionizing radiation on recovery of endothelial cells. I assessed the differences in 
the vascular structure 2 weeks after irradiation using immunohistochemistry and 
immunofluorescence. By using immunohistochemistry I stained sinusoidal endothelial cells 
with anti-endomucin antibody and determined that the bone marrow vasculature of both WT 
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and KO mice was severely affected by the irradiation displaying perturbed in morphology, 
size and number of the vessels (Fig. 46a). Analysis of the total cellularity of bone marrow 
revealed a pronounced 95% decrease in cell numbers as compared to steady state but I 
detected no differences between WT and KO mice subjected to radiation assault (Fig. 46b). 
	
Figure 46 Vascular and bone marrow structure differences between WT and KO mice after myeloablative 
assault. (a) Immunohistochemistry stained bone marrow sections of endomucin (brown) and co-stained with 
Haematoxylin. Bar graph represents 100µm. (b) Bar graph depicting total cell number of CD45+ live cells 
comparison between the WT and KO at steady state (WT, KO) and 2 weeks post irradiation (WT 2wpi, KO 2wpi) 
obtained from two independent experiments n=11 and three independent experiments n=14 respectively. Data is 
presented as Mean ± SD. Statistical significance was calculated using the Mann-Whitney U test. 
	
 
  To unveil quantitative changes in the vessel structure, I utilized confocal microscopy. 
Under high magnification (Fig. 47a), I was able to determine the vascular number, area of 
each vessel’s lumen and total area taken by the vessel lumen in the region of interest. This 
data effectively describes endothelial network properties that are macroscopic. Surprisingly, 
in contrast to the data obtained for the steady state, where total vascular area increased by 
~56%, I observed mild ~20% increase of the KO total area of vasculature after exposure to 
radiation in comparison to WT littermates after irradiation (Fig. 47b). However, loss of 
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endothelial PHD2 resulted in a prominent ~33% decrease in the KO vessel numbers as 
compared to WT littermates. In contrast, during steady state, KO vascular number had milder 
~16% decrease in vessel number compared to WT littermates (Fig. 47c). Similarly to total 
vascular area, assessment of average vessel size of the KO mice displayed ~41% increase 
in average vessel size. This data is in stark contrast to the steady state where the average 
vessel size increased by 80% in KO mice versus WT littermates (Fig. 47d). This data 
indicates that upon exposure to an ionizing radiation, loss of endothelial PHD2 leads to a 
decreased formation of new vessels numbers. However, this decreased formation of vessel 
number does not result in significantly lower vascular size.  
 
	
Figure 47 Changed morphology of bone marrow endothelium in Flk1:cre-PHD2f/f KO mice following non-
lethal radiation exposure. (a) Immunofluorescence images of 10µm thick paraffin sections of bone marrow 
obtained from WT and KO littermates depicting nuclei (DAPI blue) and endothelial cells (A594 red). Images have 
been taken with a confocal microscopy using 60x magnification. Quantitative analysis of vessels depicting total 
area of vessels in quantified region, vessel number and vessel lumen area (b). Data comparison obtained from 
analysis of images between WT and KO at steady state (WT, KO) and WT and KO 2 weeks post irradiation (WT 
2wpi, KO 2wpi). Total vascular area (a), vessel number (b) and average vessel size (c) were assessed in both 
conditions. The Data is presented as Mean ± SD. Statistical significance was determined using the Mann-Whitney 
U test. 
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4.2.2.2 Loss of PHD2 in endothelial cells does not influence oxygenation of the 
bone marrow 2 weeks after non-lethal irradiation 
	
Endothelial cell dysfunction and apoptosis leads to the discontinuity of vessels (Doan 
et al. 2013). The endothelial cell dysfunction after a single ablative dose of irradiation (12 to 
25Gy) led to decreased tumor hypoxia thereby normalizing tumor vasculature (Lan et al. 
2013). Kinetics of tumor vascularization following a single high dose of radiation therapy in 
tumors revealed an initial decrease in oxygenation within hours of irradiation, and then a 
substantial increase in the hypoxic areas within a few days post myeloablation (Song et al. 
2014). Loss of PHD2 in endothelial cells has also been shown to alter tumor oxygenation 
(Mazzone et al. 2009). Therefore, I hypothesize that the oxygenation of bone marrow will be 
negatively changed in KO mice after myeloablation. I assessed bone marrow sections taken 
from WT and KO mice sacrificed at 2 weeks after myeloablative stress for hypoxic regions 
using immunofluorescence (Fig. 48a). Quantitative image analysis (Collinet et al. 2010) 
revealed no difference in the oxygenation of bone marrow between WT and KO littermates 
(Fig. 48b). 
	
Figure 48 No differences observed between bone marrow of KO and WT mice after exposure to a non-
lethal irradiation. (a) 10µm bone marrow sections stained with a fluorescently labeled antibody against 
pimonidazole (A594 red) and with DAPI staining nuclei (blue). Images were taken on with confocal microscope on 
60x magnification. Bar graph represents 50µm. (b) Quantitative analysis of hypoxic area per region of interest. 
Data obtained from one experiment 3WT vs 3KO with 15 images analyzed for each. The statistical significance 
was determined using the Mann-Whitney U test. 
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4.2.2.3 Loss of PHD2 in endothelial cells impacts endothelial cell pericyte 
coverage 2 weeks after myeloablative assault 
	
Pericytes envelope endothelium to assure vessel integrity and stability. Pericyte 
presence is correlated with vessel recovery (Jain 2013). Importantly, pericyte covered 
vessels are less susceptible to regression (Gee et al. 2003). To determine whether PHD2 
deficient endothelial cells influence pericyte numbers, I evaluated the pericyte coverage of 
sinusoidal endothelial cells. To determine whether PHD2 loss impacted pericytes associated 
with endothelial cells, I assessed NG2 positive cell signal adjacent to vasculature.  To 
visualize endothelial cells in immunofluorescent staining of bone marrow sections, I used a 
sinusoidal endothelial specific marker – endomucin while I used the previously described 
NG2 surface marker (Fig. 49a). I first observed a decrease in pericytes in both WT and KO 
when compared to steady state. However, I observed a decrease in the NG2 positive cell in 
the proximity of endothelial cells is of similar degree when contrasted with steady state (Fig. 
49b). This data indicates that loss of PHD2 from endothelial cells does not impact pericytes 
in KO mice following the myeloablative stress.  
	
Figure 49 Pericyte coverage of PHD2 deficient endothelial cells is decreased after ionizing radiation 
exposure. (a) 10um bone marrow sections were stained with DAPI (blue), endomucin (red A594) and NG2 
(green A488). The entire NG2 signal within one width of cells from endomucin positive cells area was quantified 
and normalized to total area surveyed (b). Sections obtained from WT and KO mice 2 weeks post irradiation (WT 
2wpi, KO 2wpi) were compared to the quantitative analysis of WT and KO sections at steady state (WT, KO). The 
Data is presented as Mean ± SD. Statistical significance was determined using the Mann-Whitney U test.  
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4.2.3 Loss of PHD2 in endothelial cells and its subsequent effect on 
hematopoietic recovery following ionizing radiation exposure  
 
Hematopoietic stem and progenitor cells are rapidly dividing cells, highly affected by 
ionizing radiation. Very low doses such as 0.95 Gy reduce the population of the stem cell 
compartment to 37% of the original (Till & McCulloch 2010). At doses above 1 Gy, severity of 
depletion and recovery of mature cells production is dose dependent. Mature enucleated 
circulating cells are unaffected by radiation exposure, thus will die at their physiological rate 
after a normal life span. Mature peripheral leukocytes are sensitive to ionizing radiation in a 
dose dependent manner. Therefore, the onset of the acute radiation syndrome depends on 
the balance of the proliferating and circulating cells. At doses between 4.5-6 Gy and without 
regeneration and supportive care, organism death occurs due to infection and hemorrhage 
(Macià i Garau et al. 2011). 
Endothelial cells have been shown to up-regulate the expression of many proteins 
upon hypoxic signaling (Dai et al. 2016; S. Wang et al. 2017). Several of these molecules, 
such as CXCL12, Notch, and TGF-β1, have been shown to be critical for signaling to HSCs 
(Blank & Karlsson 2015). Moreover, the regeneration of endothelial cell in bone marrow 
facilitates hematopoiesis after myeloablation (Hooper et al. 2009; Poulos et al. 2015). I 
hypothesize that changes in signaling upon PHD2 deactivation by endothelial cells will result 
in the improved recovery of the hematopoietic compartment after ionizing radiation assault. 
To assess these changes, I examined the mature cell numbers in blood using hematological 
analysis. 
 
4.2.3.1 Loss of PHD2 in endothelial cells leads to facilitated leukocyte increase 
during late stages of hematopoietic recovery after myeloablative 
radiation 
 
The earliest observed decrease in cell numbers associated with moderate/high 
radiation exposure is a drop in lymphocytes, also referred to as lymphopenia. Lymphocytes 
are the most radiosensitive amongst all lineages. A dose above 3 Gy is sufficient to induce 
death in 90% of the circulating lymphocytes (Nakamura et al. 2010). In contrast to 
lymphocytes, mature granulocytes are not affected by radiation (Stankova et al. 2010). The 
most significant cell in this compartment are the neutrophils. However, their life span ranges 
from 7-24 hours, thus they disappear from circulation shortly after radiation exposure, 
similarly to lymphocytes. Third important cell type constituting leukocyte blood fractions are 
monocytes. Similarly to neutrophils, monocytes are more radioresistent than lymphocytes, 
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are derived from the same common progenitors, and their lifespan does not exceed more 
than seven days (Patel et al. 2017). 
T cell interactions with vascular endothelial cells link the immune and circulatory 
systems due to its codependence (J. Choi et al. 2004). Similarly myeloid progenitors localize 
in proximity to endothelial cells in bone marrow (Rafii et al. 1995) thus, I hypothesize that 
loss of PHD2 from endothelial cells results in facilitated leukocyte recovery. Analysis of 
lymphocyte and monocyte recovery following non-lethal irradiation revealed an increased 
kinetics of cell number in KO relative to WT littermates (Fig. 50a and b). Shortly after ionizing 
radiation exposure, I observed a dramatic drop in the lymphocyte, monocyte and neutrophil 
number that persisted until 2 weeks in case of neutrophil (Fig. 50c) and 4 weeks in case of 
lymphocytes and monocytes after the assault (Fig. 50a and b). Interestingly, I then noted 
similar recovery of lymphocytes and monocytes pattern while neutrophils recovery differed in 
kinetics and changes between WT and KO.  
Shortly, lymphocyte and monocyte recovery began from week five and six 
respectively when I observed a continuous increase of these cell numbers in both KO and 
WT littermates each week. Interestingly, monocyte recovery kinetics was more similar to 
lymphocytes and different from neutrophils, despite sharing common progenitor with 
neutrophil (Fig. 50a and b). In contrast I have observed no changes in neutrophil recovery 
during first 10 weeks after radiation exposure (Fig 50c) despite initial difference at steady 
state.  
Due to the fact that lymphocyte and monocyte numbers in KO mice were significantly 
increased at steady state (referred on the graph as ss) this result indicate that after bone 
marrow full recovery, PHD2 loss on endothelial cells resumed signaling that facilitated 
increase in numbers of lymphocytes and monocytes. Moreover, differential recovery of 
monocytes and neutrophils indicates that an increase in monocyte recovery is not due to the 
increase in common myeloid progenitors preGM, but through other lineage specific 
mechanism. Remarkably loss of PHD2 from endothelial cells does not lead to changes in 
gene expression responsible for facilitation of neutrophil recovery. Oddly, lack of significant 
increase in neutrophil numbers late after recovery suggests irreversible radiation induced 
changes on PHD2 lacking endothelial cells. 
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Figure 50 Leukocytes recovery following non-lethal irradiation. Recovery of lymphocyte (a) monocyte (b) and 
neutrophil (c) numbers following non-lethal radiation exposure. X axis depicts time in weeks following the 
radiation. Initial differences of lymphocyte numbers in non-irradiated time point (NI). Data pulled from two 
independent experiments. N=7-10. The data depicted as mean±SD. Statistical significance was determined using 
the Mann-Whitney U test. 
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4.2.3.2 Loss of PHD2 in endothelial cells does not impact platelet recovery 
 
Circulating platelets have a life span of about 10 days and are radioresistant. 
However, thrombocytopenia along neutropenia poses a common dose-limiting factor in 
radiotherapy treatment. A low platelets level results in life threatening internal bleeding. 
Megakaryocytes are dependent on endothelial cell interactions in steady state bone marrow 
(Avraham et al. 1993), as well as following radiation injury (Niswander et al. 2014). Moreover, 
megakaryocytes have been shown to be significantly radiosensitive (Kashiwakura et al. 
2009). I hypothesize that the endothelial cells altered signaling, upon PHD2 inactivation, will 
facilitate megakaryocyte recovery. Analysis of thrombocyte recovery revealed no differences 
in the platelet compartment after the myeloablative assault (Fig. 51). This result indicates that 
gene expression induced through PHD2 inactivation on endothelial cell does not involve any 
megakaryocyte specific genes. 
	
Figure 51 Platelet recovery following non-lethal irradiation. Recovery of platelet numbers following non-lethal 
radiation exposure. X axis depicts time in weeks following the radiation. Initial differences of platelet numbers in 
steady state (ss). Data pulled from two independent experiments. N=7-10. Data depicted as mean±SD. Statistical 
significance was determined using the Mann-Whitney U test. 
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4.2.3.3 Loss of PHD2 in endothelial cells leads to improved recovery of RBC 
compartment 
	
Mature non-nucleated erythrocytes are radiation resistant, as exposure to 200 Gy of 
ionizing radiation failed to alter their morphology (Davis et al. 1950). Moreover, due to the 
long life span of erythrocytes, ~120 days in humans (~45 in mice), anemia is an unusual 
finding due to hemorrhage. However, erythrocyte production has to be continuous to sustain 
homeostatic oxygen delivery. Thus, a significant drop in erythrocyte content is observed 
before the newly synthesized erythroid progenitors resume red blood cell production, 
irrelevant of the radiation dose (Joseph et al. 2013). Interestingly, RBCs have been known to 
be the first cells to reveal hematopoietic restoration after myeloablation (Greinix et al. 1994; 
Torres et al. 2001). Since endothelial cells and RBCs are interconnected, I hypothesize that 
PHD2 inactivation on endothelial cell changes in gene expression will induce a facilitated 
recovery of the RBC compartment. I determined the kinetics of RBC, HCT and HGB recovery 
after non-lethal irradiation. Indeed, in both KO and WT mice, the initial drop in RBCs, HGB, 
and HCT was observed. KO mice displayed a significantly lower decrease in RBC number. 
Moreover, the erythrocyte number recovered faster (between 2 and 3 weeks) compared to 
WT littermates (between 3rd and 4th week)(Fig. 52a). Similarly, the HGB and HCT initial drop 
after myeloablation was reduced, and I observed a more rapid recovery relative to WT 
littermates (Fig. 52b and c).  
 
	
Figure 52 RBC compartment recovery following non-lethal irradiation. Recovery of red blood cell (RBC) 
numbers (a), hemoglobin (HGB) (b) and hematocrit (HCT) (c) following non-lethal radiation exposure. X axis 
depicts time in weeks following the radiation. Initial differences of cell numbers in non-irradiated time point (NI). 
Data pulled from two independent experiments. N=7-10. Data depicted as mean±SD, Statistical significance was 
calculated using the Mann-Whitney U test, 
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These results clearly indicate that changes in RBC progenitors result in the facilitated 
recovery of the RBC compartment.  
 
4.2.4 Mechanism of increased RBC numbers is not due to an increase in 
hematopoietic stem cell frequency or activity in bone marrow or the 
spleen, 2 weeks after irradiation 
 
HSCs have been shown to directly drive erythropoiesis upon erythroid stress (Singh 
et al. 2018). To determine whether an increase in the RBC compartment observed in KO 
mice is due to increased activity of progenitors, I first hypothesize an increase in the most 
quiescent HSC. To detect changes between KO and WT recovery, I assess cell recovery in 
the endothelial and the hematopoietic compartment at 2 weeks post irradiation. Based on the 
results form hematopoietic recovery (Fig. 53) two weeks marks the increase in RBC 
production of KO mice while a similar increase is delayed one week in WT littermates.  
 The high output of red blood cell production requires the monumental magnification 
effects of mature cell production. This expansion is achieved by hierarchical organization of 
erythrocyte differentiation. From the fate decision until mature cell, it takes about 19-21 days 
for a erythrocyte to be detected in the periphery. It has been shown that upon stress 
induction, HSCs might circumvent the hierarchical differentiation ladder and differentiate 
directly into the progenitor of interest (Singh et al. 2018). Therefore, I hypothesize that the 
difference I observed in earlier RBC production is due to the changes inflicted on 
hematopoietic stem cell progenitors.   
I used FACS to assess multipotent progenitors. The LSK compartment did not differ 
in frequencies or absolute cell numbers between WT and KO littermates 2 weeks after 
irradiation (Fig. 53a). Similarly, analysis of each HSC, MPP2, and MPP3/4 populations 
revealed no difference between the WT and KO mice frequency and absolute numbers 
(Fig.53b c and d). 
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Figure 53 Frequency and absolute cell numbers of LSK cells and their subsequent populations in the 
bone marrow after non-lethal irradiation. FACS results of frequency (upper graphs) and absolute cell numbers 
of each LSK HSC, MPP2 and MPP3/4 cells. Data pulled from three independent experiments. n=14. The Data is 
presented as Mean ± SD. Statistical significance was determined using the Mann-Whitney U test. 
 
To fully characterize the activity of hematopoietic stem cells, I analyzed the cell cycle 
status of multipotent progenitors and stem cells. Ionizing radiation exposure selectively 
increases the frequency of HSCs in the resting phase of the cell cycle (Y. Wang et al. 2006). 
Interestingly, endothelial cells regulate the hematopoietic stem cell life cycle (Ramalingam et 
al. 2017). I hypothesize that changes in endothelial signaling lead to an increase in actively 
cycling of the most undifferentiated progenitors.  
I analyzed the cell cycle of the most of the undifferentiated populations of the LSK 
compartment using FACS. I observed no differences in the G1, SG2M and G0 cell cycle 
fractions in the HSC compartment between WT and KO littermates (Fig. 54a). Similarly, no 
differences were noted in all three cell cycle stages of MPP2 (Fig. 54b) as well as MPP3/4 
(Fig. 54c) This result indicates that endothelial cell signaling upon loss of endothelial PHD2 
inactivation does not result in the enhanced cell cycle activity of the KO HSPCs 
hematopoietic stem cells.  
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Figure 54 Frequency of cell cycle status of each of the undifferentiated progenitors from LSK population 
in bone marrow after non-lethal radiation. Graphs of three cell cycle stages G0, G1, SG2M analyzed for each 
constituent of LSK cell populations.  Data obtained from one independent experiment n=5-8. The Data is 
presented as Mean ± SD. Statistical significance was determined using the Mann-Whitney U test. 
 
Myeloablative stress leads to the relocation of hematopoietic stem and progenitor 
cells into the spleen (Morrison et al. 1997). I hypothesize that I will observe an increase in the  
hematopoietic compartment in the spleen upon “primed” endothelial cell signaling. To assess 
any changes in the LSK compartment of the spleen I used FACS. Analysis revealed no 
significant differences in the LSK compartment between WT and KO littermates (Fig 55a). In 
a detailed analysis of each of the progenitor population constituting this compartment – HSC, 
MPP2 and MPP3/4 was not significantly changed between WT and KO littermates (Fig. 55b, 
c and d). The total splenic cell number did not change between WT and KO littermates (Fig. 
55e). This result indicates that loss of PHD2 in endothelial cells did not change 
hematopoietic stem and progenitor relocation into the spleen.  
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Figure 55 Frequency and absolute cell numbers of LSK cells and subsequent three populations 
constituting LSK cells in the spleen after non-lethal irradiation. FACS results of frequency (upper graphs) 
and absolute cell numbers of each LSK HSC, MPP2 and MPP3/4 cells. The data pulled together from two 
independent experiments. n=10-13. Data is presented as Mean ± SD. Statistical significance was calculated using 
the Mann-Whitney U test. 
 
4.2.4.1 Increase of RBC numbers in KO mice is not due to changes in lineage 
committed erythroid progenitors in bone marrow or the spleen 
 
Since I observed no changes in undifferentiated stem and progenitor populations, I 
hypothesize that endothelial cell signaling impacted lineage committed erythroid 
progenitors/precursors. Therefore, I analyzed the frequency and activity of erythroid lineage 
committed hematopoietic progenitors in the bone marrow and in the spleen. 
FACS analysis of bone marrow erythroid lineage progenitors for erythrocyte specific 
progenitors preMegE, preCFUe and CFUe’s at 2 weeks post irradiation did not reveal any 
differences in frequency and absolute numbers between KO and WT mice (Fig 56a, b, c).  
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Figure 56 Erythroid lineage committed progenitors in bone marrow are unchanged 2 weeks after 
irradiation.  FACS analysis of pre megakaryocyte/erytrhroid progenitors(preMegE) (a) and pre colony forming 
units (preCFUe) and colony forming units (CFUe)(b) in bone marrow. Data pulled from three independent 
experiments n=14. . Data for all depicted graphs are mean±SD, Statistical significance was calculated using the 
Mann-Whitney U test, 
 
To determine whether the cell cycle activity in lineage committed progenitors is 
responsible for an observed increase in the RBC numbers, I assessed cell cycle of erythroid 
committed progenitors by flow cytometry.  
FACS analysis revealed an increase in the frequency of bipotent megakaryocyte-
erythrocyte progenitor (PreMegE) in quiescence with a simultaneous decrease in the 
frequency of cells in the G1 phase (Fig 57a).  The other progenitors preCFUe and CFUe 
remained unaltered (Fig. 57b).  
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Figure 57 The cell cycle status of bone marrow erythroid progenitors 2 weeks after irradiation. Analysis of 
the cell cycle of preMegE (a) preCFUe (b) and CFUe (c) analysed by FACS. Representative data of one 
experiment n=6-8. Data for all depicted graphs are mean±SD. Statistical significance was determined using the 
Mann-Whitney U test.  
 
This result indicates that the bipotent progenitor of megakaryocytes and erythrocytes 
could have received cues from endothelial cells upon PHD2 inactivation. However the 
observed changes do not explain the increase in RBC numbers, 2 weeks after irradiation.  
 
4.2.4.2 The RBC increase cannot be explained by the changes of lineage 
committed erythroid progenitors in the spleen 
 
To determine whether PHD2 lacking endothelial cells signaled to erythroid lineage 
committed progenitors in the extramedullary tissue – spleen, I utilized FACS. No differences 
in bipotent progenitors preMegE were observed (Fig. 58a). Similarly, KO erythroid lineage 
progenitors preCFUe and CFUe were unchanged compared to WT littermates (Fig. 58b and 
c) 
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Figure 58 Erythroid lineage committed progenitors are unchanged in the spleen 2 weeks post irradiation.  
FACS analysis of pre megakaryocyte/erytrhroid progenitors (preMegE) (a), pre colony forming units (preCFUe) 
and colony forming units (CFUe)(b) in the spleen. Data pulled from two independent experiments n=9-8. The data 
for all depicted graphs are mean±SD. Statistical significance was calculated using the Mann-Whitney U test. 
 
These results, taken together with HSPC analysis of the spleen, indicate that loss of 
PHD2 in endothelial cells does not mediate the effect of increased extra medullary 
mobilization upon radiation injury.   
 
4.2.4.3 Loss of PHD2 in endothelial cells influenced erythroblast precursors in 
bone marrow of KO mice 2 weeks post irradiation 
 
The last stages of erythroid differentiation are dependent on subsequent mitotic 
divisions of erythroblasts (section 3.6.2). Therefore, I analyzed erythroblasts in bone marrow 
using FACS.  
Analysis of terminally differentiated populations revealed a decrease in the 
frequencies of all bone marrow precursors. I observed a decrease in proerythroblasts, 
basophilic erythroblasts, polychromatic erythroblasts and ortochormatic erythroblasts (Fig 
59a). Simultaneously, I observed a significant increase in reticulocyte numbers in bone 
marrow (Fig. 59a). Reticulocytes are the last stage or RBC maturation – these cells are 
cycling in periphery. I therefore checked whether observed increase in reticulocyte count in 
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bone marrow is also prominent in the periphery. Analysis of peripheral blood with the 
hematology analyzer showed a significant increase in reticulocyte numbers (Fig. 59b).  
	
Figure 59 significant decreases of all erythroblast populations in the bone marrow after myeloablative 
assault. FACS analysis of all erythroblast populations from bone marrow: proerythroblasts, basophilic 
erythroblasts, polychromatic erythroblasts, ortochromatic erythroblasts, reticulocytes/RBC.  Data from one 
independent experiment n=5-8. Data for all depicted graphs are mean±SD. Statistical significance was 
determined using the Mann-Whitney U test. 
 
This result indicates that loss of PHD2 in endothelial cells impacted erythroblast 
precursors. However the significant decrease in erythrocyte precursors does not explain 
observed phenotype of increase RBC numbers in periphery.  
 
4.2.4.4 Splenic erythroblasts are not changed upon PHD2 loss from 
endothelial cells, 2 weeks post irradiation 
 
To determine whether erythroblasts in the spleen were influenced by changed 
endothelial signaling, I utilized FACS.  
Splenic pro-erythroblasts were undetectable in the spleen of both WT and KO mice 
(data not shown). I observed no changes in any of the later precursors such as basophilic 
erythroblasts, polychromatic erythroblasts, ortochromatic erythrhroblasts and reticulocytes in 
the spleen (Fig. 60).  
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Figure 60 Erythroblasts precursors in the spleen are unchanged 2 weeks post irradiation. FACS analysis of 
basophilic erythroblasts, polychromatic erythroblasts, ortochromatic erythroblasts, reticulocytes/RBC in the 
spleen.  Data from one independent experiment n=4-8. Data for all depicted graphs are mean±SD, Statistical 
significance was calculated using the Mann-Whitney U test 
	
This result indicates that PHD2 inactivation in endothelial cells does not affect 
erythroblast differentiation and activity in the spleen.  
 
4.2.4.5 EPO levels are not responsible for the decrease in erythroid precursors 
in bone marrow, 2 weeks after irradiation   
 
Erythroid progenitors and precursor activity is heavily dependent on the erythropoietin 
levels (Migliaccio et al. 1996). Hypoxic signaling on renal cells elicits high EPO production, 
leading to strongly increased RBC, HCT, HGB levels (Franke et al. 2013). To exclude 
increased EPO levels influencing the increased erythroblast precursors maturations, I have 
compared EPO levels between WT and KO littermates using an ELISA-based analysis. This 
method enables a quantitative assessment of EPO but revealed no difference between WT 
and KO littermates (Fig. 61). 
	
Figure 61 Erythropoietin levels are comparable between WT and KO mice. Serum levels of Erythropoietin 
measured by ELISA. Data pulled from two experiments n=8. Data for all depicted graphs are mean±SD, 
Statistical significance was calculated using the Mann-Whitney U test 
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This result indicates that altered endothelial cell signaling influences differentiation of 
the erythroblast precursors in the bone marrow, which is not a result of an indirect increase 
of EPO acting directly on erythroblasts.   
 
4.2.4.6 Increased numbers of circulating red blood cells is not due to faster 
erythrocyte production 
 
 A steady decrease in red blood cell production was prevalent in both WT and KO 
upon radiation treatment at a non-lethal level. Although low doses of radiation (1 Gy) do not 
deplete the entire erythrocyte progenitor compartment, non-lethal assault is detrimental to 
erythrocyte progenitors and their precursor compartment (Peslak et al. 2012). Unlike rapid 
splenic expansion of erythroblasts in anemia, erythropoiesis after exposure to radiation is 
delayed, occurring after hematopoietic recovery. To determine whether analysis of 
erythrocyte progenitors and precursors at 2 weeks is not informative due to the snapshot 
information on progenitor frequency and activity I sought to determine the kinetics of 
erythrocyte production.  
To assess RBC production, I injected GFP positive (GFP+) RBC IV into the WT and 
KO Flk1:cre-PHD2f/f GFP negative (GFP-) recipient mouse. By observing the ratio of newly 
injected RBC to endogenous RBC produced by the recipient mouse, I can conclude whether 
or not cell production is enhanced. To ensure that the kinetics of RBC production is 
unchanged during steady state, I performed this experiment on non-irradiated mice first (Fig 
62a) and then I determined the kinetics of new erythrocyte production following irradiation 
(Fig 62b). I observed no differences between WT and KO RBC production kinetics during 
steady state (Fig. 62a). Observation of GFP+ erythrocyte levels following non-lethal radiation 
in both WT and KO mice, I observed a rapid decrease around day 19 (Fig. 62b). In contrast, I 
observed increase in total red blood cell number in periphery between day 14 and 21 after 
irradiation (Fig. 62c). Therefore, an observed decrease in GFP+ RBC around day 19 marks a 
notable increase in erythrocyte production in both WT and KO littermates. This finding 
provides evidence that the recovery of erythroid progenitors happens during similar timelines 
in KO and WT littermates.  
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Figure 62 Red blood cell production kinetics is not different between WT and KO littermates in steady 
state and after irradiation. RBC production depicted as ratio of GFP+ exogenous RBC to endogenous GFP- red 
blood cells during steady state (a) and following non-lethal irradiation assault (b). RBC number recovery following 
non-lethal radiation assault depicting changes in RBC number over the time course of 21 days. Data depicted 
from one independent experiments. N=5-10. The data are depicted as mean ± SD. Statistical significance was 
determined using the Mann-Whitney U test. 
 
The above experiment relays on changes of the GFP+ RBC frequency in relation to 
GFP- RBC we can safely conclude that the differential RBC number in periphery of KO mice 
is not the RBC production. Therefore, these data further strongly suggest that increased 
numbers of RBCs following myeloablative stress are due to the decreased total erythrocyte 
clearing.  
 
4.3 Characterization of the influence of the transcription factor HIF-2α in 
mice lacking EC PHD2 
4.3.1 The molecular signal transduction upon PHD2 inactivation is mediated 
by the HIF-2 transcription factor.  
 
The change in BM endothelial morphology, increase in peripheral leukocytes, 
changes of hematopoietic stem and progenitor cells in bone marrow differentiation, 
impairment of the marginal zone B cells during the steady state, as well as the increased 
recovery of the RBC compartment following radiation therapy are due to the loss of PHD2 
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from endothelial cells. To unravel the downstream mechanism, I sought to first determine the 
transcription factor responsible for the altered signaling of endothelial cells.  
Lack of an oxygen sensor (PHD2) in KO mice results in the stabilization of hypoxia 
inducible transcription factors responsible for the activation of specific gene expression. 
Subunits α are short lived (Huang et al. 1996). There are three isoforms of α subunit (HIF-1α, 
HIF-2α and HIF-3α), and of these HIF-1α and HIF-2α play special role in cellular response to 
oxygen by binding hypoxia response elements, ultimately regulating gene expression 
(Zagórska & Dulak 2004). Remarkably, HIF-1α have been shown to predominantly control 
the reaction to acute hypoxia whereas HIF-2α drives the response to chronic low oxygen 
exposure (Holmquist-Mengelbier et al. 2006). Interestingly, both isoforms have been shown 
to elicit differential responses in a tissue dependent manner (Rosenberger et al. 2002; 
Wiesener et al. 2002). Additionally, HIF-2α is an important hypoxia response mediator in 
endothelial cells (Dai et al. 2016; Meneses & Wielockx 2016; Rankin et al. 2007).  
I hypothesize therefore that the phenotype observed in Flk1:cre-PHD2f/f single KO 
mice is mediated by the HIF-2α transcription factor. To determine this, we generated a 
double KO mouse line with PHD2 and HIF-2α ablated in the endothelial cells. Creating such 
double knockout (DKO) mice should result in reversal of the phenotype observed in KO mice 
under assumption that PHD2 loss would lead to stabilization of HIF-2α transcription factor.  
 
To generate the double knockout mouse I have crossed Flk1:cre-PHD2f/f with HIF-2α 
floxed mice (Gruber et al. 2007). The result of the breeding was generation of mice with the 
conditional deletion of PHD2 and HIF-2α from endothelial cells.  
 
4.3.2 Loss of PHD2 and HIF-2α  from endothelial cells partially rescues 
alterations in bone marrow endothelial cell morphology  
 
To determine whether the observed phenotype in single KO mice are reversed, I first 
sought to determine the bone marrow endothelial changes between WT and DKO 
littermates. Haematoxylin and eosin staining of bone marrow sections did not reveal any 
changes in the bone marrow structure. I then stained the bone marrow sections for 
sinusoidal endothelial marker, endomucin, to determine changes in the vasculature. No 
alterations in vascular structure were detected (Fig. 63a). However, I previously observed a 
similar phenotype in bone marrow sections of steady state single knockout (page 27). 
Similarly, quantitation of total bone marrow cells revealed no differences between WT and 
KO littermates (Fig. 63b) 
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Figure 63 Vascular and bone marrow structure differences between DWT and DKO mice. (a) 10µm thick 
femoral bone marrow paraffin sections stained with haematoxylin and eosin. Bar graphs represent 50µm. (b) 
Immunohistochemistry stained sections of endomucin (brown) and co-stained with Haematoxylin. Bar graph 
represents 100µm. (c) Bar graph depicting total cell number of CD45+ live cells obtained from one experiments 
n=3. The Data is presented as Mean ± SD. Statistical significance was determined using the Mann-Whitney U 
test. 
 
Therefore, I quantitatively analyzed the assessed morphology of ECs. To determine 
changes in the vascular lumen and vessels, I used immunofluorescence to stain for 
sinusoidal endothelial cells using endomucin and DAPI to visualize nuclei (Fig. 64a). 
Remarkably, the sinusoidal lumen area of DKO mice was increased by ~34% (Fig 64b) as 
opposed to the ~86% increase between WT and single KO littermates. Similarly, previously 
observed ~15% reduction in vessel number between WT and single KO in DKO vs WT 
littermates revealed only ~6% decrease (Fig. 64c). Lastly, the total vascular area per region 
of interest increased ~18% in DKO compared to WT littermates (Fig. 64d). In contrast single 
KO total vascular area differed from its WT littermate by ~56%.  
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Figure 64 Partially reversed morphology of bone marrow endothelium in Flk1:cre-PHD2f/fHIF2f/f (DKO) 
mice. (a) Immunofluorescence images of 10µm thick paraffin sections of bone marrow obtained from WT and KO 
littermates depicting nuclei (DAPI blue) and endothelial cells (A594 red). Images have been taken using confocal 
microscopy with 60x magnification. Quantitative analysis of vessels depicting total area of vessels in quantified 
region (d), vessel number (c) and vessel lumen area (a). Data obtained from analysis of images from 3WT and 
3KO mice.  Data is presented as Mean ± SD. Statistical significance was determined using the Mann-Whitney U 
test. 
 
Analysis of the morphology revealed a partial reversal of the endothelial cell 
phenotype, implying that effects observed in PHD2 knockout mice are at least in part 
mediated by the HIF-2α transcription factor.  
 
4.3.3 Simultaneous loss of PHD2 and HIF-2α  in endothelial cells completely 
reverses the hematopoietic phenotype observed in KO mice.  
 
Next, I assessed changes in the hematopoietic compartment of the Flk1:cre-
PHD2f/fHIF2f/f DKO mouse. Analysis of the peripheral blood revealed a complete reversal of 
the observed phenotype in double knockout mice as compared to single KO results (Fig 67). 
To make a valuable comparison, I presented data from the single knockout Flk1:cre-PHD2f/f 
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(KO – color red) and their WT littermates (WT – color black) versus double knockout 
Flk1:cre-PHD2f/fHIF2f/f (DKO – color black) and its WT littermates (DWT – color black) for all 
measurements obtained in the periphery of the respective mice. Measurements were 
acquired using hematology analyzer.  
Analysis of the RBC compartment revealed a complete reversal of the single KO 
phenotype. DKO mice did not reveal any significant decrease in the RBC compartment in 
comparison to its littermates  
 
	
Figure 65 DKO mice display normal RBC numbers. Graphical representation of red blood cell (RBC) number 
(a), hemoglobin (HGB) concentration (b) and hematocrit (HCT) (c). in KO and its WT littermates (black and red) 
and DKO and its DWT littermates (black and blue). Representative data is pulled from three independent 
experiments n=20-11. Data is presented as Mean ± SD. Statistical significance was determined using the Mann-
Whitney U test. 
 
Similarly to RBC, platelet levels of DKO mice did not reveal any significant differences 
when compared to their WT littermates. This result is opposed to a significant ~20% 
decrease in platelet number in single KO when compared to its WT littermates (Fig. 66).   
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Figure 66 DKO mice display normal platelet number in peripheral blood. Hematology analysis of the platelet 
(PLT) number in peripheral blood. Data pulled from three independent experiments n=20-11. Data is presented as 
Mean ± SD, Statistical significance was calculated using the Mann-Whitney U test, 
 
Correspondingly, no changes were observed between DKO and its DWT littermate 
within the entire white blood compartment (Fig. 67). In comparison previously I observed 
~70% increase of KO WBC relative to WT littermates. 
	
Figure 67 Flk1:cre-PHD2f/fHIF2f/f double knockout mice and their WT littermates have comparable  white 
blood cell numbers in the peripheral blood. of the white blood cell (WBC) number in peripheral blood. Data 
pulled from three independent experiments n=20-11. Data is presented as Mean ± SD. Statistical significance 
was determined using the Mann-Whitney U test. 
 
Within the WBC compartment, the hematology analyzer can distinguish three cell 
types – monocytes, neutrophil and lymphocytes. In a detailed analysis confirmed DKO 
reversal of the previously observed phenotype of KO (Fig. 68). 
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Figure 68 Flk1:cre-PHD2f/fHIF2f/f double knockout mice and their WT littermates have comparable 
leukocyte numbers in the peripheral blood. Monocyte (a), neutrophil (b) and lymphocyte (c) number analysis 
of peripheral blood. Data pulled from three independent experiments n=20-11. Data is presented as Mean ± SD. 
Statistical significance was determined using the Mann-Whitney U test. 
This effect indicates that the observed phenotype in single KO mice was mediated by 
the HIF-2α transcription factor changes in the gene expression of endothelial cells.  
 
4.3.4 HIF-2α  transcription factor induce signaling on endothelial cells that 
leads to marginal zone B cell impairment 
 
To fully characterize the phenotype observed in KO mice, I also assessed the 
marginal zone B cells from the spleen of DKO mice and their WT littermates by utilizing 
FACS. Presented are data from single knockout Flk1:cre-PHD2f/f (KO – color red) and their 
WT littermates (WT – color black) as well as data obtained from double knockout Flk1:cre-
PHD2f/fHIF2f/f (DKO – color black) and its WT littermates (DWT – color black). Data for this 
experiment obtained by FACS has been compared to similar numbers of mice in KO, WT 
setting.  
Whereas KO mice showed a prominent decrease in marginal zone b cells (WT 
mean=4,1 vs KO mean=0,6; p=0,01), DKO mice did not display significantly changed 
numbers (Fig 69a). Also follicular cell frequency and numbers remained unchanged between 
KO and its WT littermate.  
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Figure 69 DKO marginal zone B cells in the spleen are unchanged in comparison to its WT littermates. 
FACS analysis of the marginal zone frequency and numbers in the spleen. Similarly analysis of Follicular cells 
frequency and total cell number from the spleen. Presented data represents one experiment experiments n=4 
(SKO) n=3 (DKO). The Data is presented as Mean ± SD. Statistical significance was calculated using the Mann-
Whitney U test. 
  
These results strongly suggest that the impairment of the marginal zone 
differentiation effect was due to the loss of PHD2 and subsequent stabilization of the HIF-2α 
transcription factor.  
 
4.3.5 Loss of PHD2 and subsequent stabilization of the HIF-2αtranscription 
factor is responsible for the increased recovery of RBCs following 
ionizing radiation  
 
To determine whether the phenotype of the facilitated recovery of RBCs is also 
rescued by silencing HIF-2α activity, in KO mice, I analyzed the hematopoietic compartment 
recovery after non-lethal irradiation in DWT and DKO mice. Presented are data from single 
knockout Flk1:cre-PHD2f/f (KO – color red) and their WT littermates (WT – color black), as 
well as data obtained from the periphery of double knockout Flk1:cre-PHD2f/fHIF2f/f  (DKO – 
color black) and its WT littermates (DWT – color black).  
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As shown in figure 74, I observed complete reversal of RBC, HGB and HCT recovery 
in DKO mice compared to KO mice, relative to their WT littermates.  
	
Figure 70 Reversal of improved RBC recovery in DKO  mice in comparison to single knockout. Depicted 
are recovery kinetics of RBC (a), HGB (b) and HCT of single knockout (SKO) and its WT littermate (SWT), as well 
as double knockout (DKO) and its WT littermate (DWT).  Data is presented as Mean ± SD 
 
Analysis of DKO mice revealed an almost complete reversal of the different 
phenotypes observed in single KO mice, strongly suggesting for a HIF-2α  mediated 
phenotype in KO mice. 
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Ongoing studies are necessary to confirm these observations and eventually will help 
to identify the downstream HIF-2α-dependent mediators. We will also determine whether 
the HIF-1α  transcription factor is at least in part also responsible for the signaling changes 
that result in alterations of hematopoietic stem cells and surrounding niche cells in our KO 
mice.  
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5 Discussion  
 
 
 
The primary function of the cardiovascular system including blood is delivery of 
appropriate levels of oxygen to all tissues. Disturbance of this constant oxygen influx causes 
local tissue hypoxia that, if not resolved can lead to multiple organ failure and ultimately 
death of the organism. Hypoxia related pathological conditions associated with decreased 
oxygen levels are lung diseases, heart pathology, anemia or vascular injury resulting from 
treatments like ionizing radiation to name a few. In addition to working towards oxygen 
delivery, hematopoietic cells, are also contingent on endothelial cell to maintain and regulate 
of their activity. Alterations in endothelial cell gene expression have been shown to greatly 
affect hematopoietic stem cell activity (Winkler et al. 2012; Doan et al. 2013). Hypoxia and its 
effect on endothelial cells has been studied intensively due to the fact that endothelial cells 
are at the interface of cells transporting oxygen and tissues that require it. However, little is 
known about the complexity of oxygen sensing and its subsequent effects on neighboring 
hematopoietic stem and progenitor cells. An understanding of endothelial and hematopoietic 
interaction is critically important for intervention and improvement of patient recovery in 
common diseases associated with oxygen deprivation such as acute radiation syndrome or 
anemia.  
In the present study, I used a genetic approach to dissect the cell-autonomous role of 
the endothelial PHD2/ HIF-2α axis in the regulation of HSPC activity. By utilizing conditional 
knockout strains in which PHD2 was inactivated, I obtained experimental evidence that HIF 
activated signaling changes decrease bone metabolism. Most importantly, I show that loss of 
PHD2 results in prominent effects on its hematopoietic stem and progenitor cell activity. 
Furthermore, I show that by modulating oxygen sensor in endothelial cells, the recovery of 
the RBC compartment after radiation stress is improved. This data translates directly to 
clinical suggestions for further studies that may improve patient phenotypes. Finally, I 
identified HIF-2α as the central mediator of effects on hematopoietic stem cell activity 
resulting in changes in the periphery of KO mice. This data additionally support crucial role of 
cell specific PHD2 inactivation and its subsequent effects on bone metabolism (Rauner et al. 
2016). 
First, I determined how loss of PHD2 oxygen sensor led to an increase in vessel 
lumen and ultimately total vessel area in the bone marrow of KO mice. Early reports based 
on high altitude hypoxia exposure described sustained vasoconstriction and vascular 
remodeling of pulmonary endothelial cells (Anon 2014; Orton et al. 1988). More recent 
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studies confirmed this effect to be specific for hypoxic signaling using EC PHD2 conditional 
knockout mice (Kapitsinou et al. 2016; Dai et al. 2016). However, these mouse models have 
the disadvantage that the hematopoietic compartment is off-targeted in addition to the 
endothelial cells.  
My data strengthens differential response of local endothelial cells to inactivation of 
PHD2 oxygen sensor. Namely, in contrast to pulmonary vasoconstriction, local bone marrow 
endothelial cells capillaries display pronounced vasodilation. Moreover, the unique mouse 
model we developed ensures the effect is endothelial specific and not an off-target effect 
related to changes in other cells. A study where HIF-2α transcription factor was inactivated 
from endothelial cells was reported to result in decreased vessel lumen (Skuli et al. 2009), 
which further supports my data and underlines the importance of oxygen sensor related 
signaling on endothelial cell morphology. Future study should determine changes of 
permeability of bone marrow endothelium in KO and WT mice.  
Interestingly, similar effects of increased vascular area and decreased vascular 
number was reported to be associated with age related effect on endothelium (Poulos et al. 
2017). Along with the morphology changes, oxygenation of the bone marrow in aged mice 
increased. A question then arises as to whether age related morphology changes could be 
the consequence of decreased oxygen level. However, mice heterozygous for PHD2 showed 
improved local oxygenation in KO mice (Mazzone et al. 2009). In a complementary 
approach, the deletion of HIF-2α from endothelial cells resulted in increased hypoxia due to 
decreased perfusion (Skuli et al. 2009). My preliminary data on oxygenation of bone marrow 
in Flk1:cre-PHD2f/f KO mice, suggests increased oxygen delivery to tissues. Interestingly, 
increase in local oxygen could result from increased permeability of bone marrow vessels. 
This result leads to the hypothesis that age-related changes in the bone marrow 
microenvironment may be reduced by increasing local oxygenation.  
 
To determine whether loss of endothelial PHD2 affects the bone marrow resident 
cells, I examined main residents of hematopoietic stem cell niche. First, I discovered a 
pronounced decrease in bone remodeling upon altered endothelial cell signaling. Endothelial 
cells and osteoblast have been shown to regulate each other’s activity. For example, 
activation of PHD2 related signaling on osteoblasts in mouse models led to a denser 
vasculature in bone marrow (Y. Wang et al. 2007; Wu et al. 2015). This resulted from an 
enhanced HIF-related osteoblast-derived VEGF production. Similarly, the vascular 
endothelium synthesizes an array of soluble mediators such as fibroblast growth factor, 
interleukin-1, interleukin-6 or colony stimulating factor. These factors can control recruitment, 
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proliferation, and differentiation of bone forming osteoblasts and bone resorbing osteoclasts 
(Mantovani et al. 1997). 
My data clearly demonstrate that upon loss of PHD2 in endothelial cells bone 
mineralization in both cortical and trabecular bone is significantly decreased. Follow up 
studies are required to determine the exact mechanism of decreased remodeling. First, we 
need to explain what is the mechanism of decrease in bone forming activity of osteoblasts, 
and osteoclast-dependent bone resorption. Additionally, due to the nature of the constitutive 
promoter used, it would be advantageous to exclude developmental changes by evaluating 
the bone phenotype in embryonic/newborn mice, or develop an inducible mouse model to 
refine the influence of hypoxia sensing on endothelial cells. We already have tamoxifen 
inducible endothelial specific conditional knockout mouse ready therefore future study will 
determine whether observed phenotype is through endothelial alterations in early 
development or is a result of signaling changes relay to bone forming and resorbing cells. 
Interestingly, similarly aging is accompanied by reduced bone strength (Bloomfield et 
al. 2002). Remarkable are striking similarities of observed phenotypes of KO mice to 
phenotypes observed in aging individuals, namely, decreased bone mineralization and 
increased in bone marrow oxygenation resulting from hyper-dilation of local bone marrow 
capillaries. It has been shown that these effects are due to HIF-related Notch signaling on 
specific endothelial cells in bone marrow (Kusumbe et al. 2014). These corresponding 
phenotypes may lead to hypothesis that by modulating of oxygen sensor in aged organisms 
we could potentially reduce age related bone marrow changes. Follow-up studies of 
comparing the gene expression of aged endothelium and of that with inactivated PHD2 
oxygen sensor could reveal novel target in therapy associated with age related conditions.  
 Interestingly, pericytes interact closely with the bone marrow vasculature. Changes in 
hypoxia sensing endothelial cell gene expression severely increases pulmonary and tumor 
vessel coverage with pericytes (Mazzone et al. 2009; Kapitsinou et al. 2016; Dai et al. 2016; 
S. Wang et al. 2017). In contrast, I found that loss of PHD2 in bone marrow endothelial cells, 
led to a significant decrease in the pericytes during both steady state and after irradiation. 
However my data, support the notion that endothelial cells are functionally distinct between 
tissues (Nolan et al. 2013; Tavassoli 1981). More research is recommended to determine 
what molecules are responsible for the observed decrease in hematopoietic niche – bone 
and pericytes. Determining endothelial specific signaling could potentially pose an 
opportunity to modify the side effects of chronic hypoxia exposure. 
 
Most importantly, I describe a profound increase of leukocytes in the peripheral blood 
alongside a minimal decrease in erythrocyte and platelets upon altered endothelial cell 
signaling following PHD2 inactivation. This effect was expected due to the fact that 
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endothelial cells are localized in the vicinity of, and regulate and maintain activity of 
hematopoietic stem cells (Rafii et al. 1995; Avecilla et al. 2004; Kiel et al. 2005).  
Analysis of bone marrow hematopoietic stem cell compartment revealed a slight 
decrease in quiescence of the proliferating multipotent progenitors but not of the most 
immature HSCs. This result supports the notion that the bone marrow vascular zone is 
important to the cells that undergo active differentiation (HEISSIG et al. 2002) by providing 
direct cues to multipotent progenitors through membrane bound receptors or cytokine 
expression. Notch signaling have been shown to increase upon inactivation of PHD2 oxygen 
sensor from endothelial cells (S. Wang et al. 2017). Moreover this type of signaling have 
been shown to regulate hematopoietic progenitor cells (Lampreia et al. 2017). Further study 
is recommended to determine the mechanism of observed changes. However, it has been 
show that even within bone marrow different endothelial cell types vary in response to 
activation of PHD2 signal transduction (Kusumbe et al. 2014). Therefore one must be aware 
that most undifferentiated hematopoietic stem cells might reside in proximity to endothelial 
cells where loss of PHD2 does not lead to transcriptional changes.  
Interestingly, I observed an increase in the frequency of the most undifferentiated 
hematopoietic stem cells in spleen. Remarkably, upon stress induction, HSCs mobilize to the 
spleen where they repopulate the damaged hematopoietic compartment (Morrison et al. 
1997). My studies support the notion that upon endothelial PHD2 inactivation the 
extramedullar, splenic HSCs frequency is increased. Moreover, they underline the finding 
that sinusoidal endothelial cells in the spleen are important for HSC support during 
extramedullary hematopoiesis (Miwa et al. 2013).  
These data suggest that loss of endothelial PHD2 inactivation either leads to the 
mobilization of bone marrow HSCs or an increased self-renewal of splenic HSCs. To discern 
between these two models, future studies will have to clarify whether plasma levels of KO 
mice increased in levels of factors known for HSC mobilization such as granulocyte colony 
stimulating factor (Bendall & Bradstock 2014) or in local bone marrow environment. This 
observation would point towards the hypothesis that changes in endothelia gene expression 
upon loss of PHD2 led to HSC mobilization. In contrast, a further analysis of splenic 
endothelial cells gene expression could reveal increased expression of molecules supportive 
to HSCs such as CXCL12 (Miwa et al. 2013). This result would indicate that loss of PHD2 on 
splenic endothelial cells induced an emergency signaling leading to observed increase of 
local HSCs. Successful analysis of these experiments could lead to improvement of 
understanding the relationship between hematopoietic progenitors and the endothelial cells 
in the bone marrow as well as the extramedullary hematopoietic niche.  
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Interestingly I observed minimal decrease in RBC production. The natural first 
assumption would be that oxygen sensor inactivation signal would lead directly to an 
increase in oxygen transporting cells. However existing data points towards macrophage-
oriented erythroid progenitor niche (A. Chow et al. 2011). My study supports that notion by 
indicating that PHD2 inactivation from endothelial cells did not alter marrow erythroid 
progenitor and precursor compartment. In contrast, I have observed significant decrease in 
splenic erythroblast populations. MAPK signal transduction has been shown to be 
modulating spleen erythropoiesis that results in significant changes in erythroblast 
populations without significant impact on RBC numbers in periphery (Guihard et al. 2010). 
Further analysis of erythroblast cycling could give an insight into the mechanism of observed 
erythrocytosis.  
Remarkably, I also observed that RBCs in Flk1:cre-PHD2f/f KO mice are increased in 
size and consequently in hemoglobin content. In this model endothelial cell signaling 
imposed increase of erythrocyte size and hemoglobin content as a response to inactivation 
of oxygen sensors. Remarkably, a study on the impact of cyclin D on erythroblast was 
reported to result in RBC macrocytosis without anemia (Jayapal et al. 2016). Such 
phenotype is not always pathological and is often found in newborns and pregnant mothers – 
situations clearly requiring increased oxygen delivery therefore I assume that an endothelial 
specific signalling results in observed phenorype. To unveil molecular mechanism of 
endothelial specific signaling leading to erythrocyte macrocytosis I suggest future study on 
erythroblast cell cycle to further our understanding of the observed phenotype. A successful 
outcome of this study could potentially improve therapy in diseases with accompanied 
anemia.  
  
I established that loss of endothelial PHD2 had a significant impact on the frequency 
of the cells and activation of the cell cycle for myeloid lineage progenitor cells in bone 
marrow. These results, observed under endothelial oxygen sensor inactivation, extend the 
view that myeloid progenitors are closely associated with the vasculature in steady state 
(Rafii et al. 1995). Interestingly, this result was complemented by an increase in splenic 
myeloid progenitor. Interactions of endothelial cell with myeloid cells has been known to be 
enhanced upon hypoxia by increase in cytokine expression (Albelda et al. 1989) leading to 
increased cell adherence and migration into tissues. However, I did not see an increase in 
myeloid cells in various tissues (data not shown). Thus, I believe that observed increased 
myeloid compartment in periphery is a result of increase in both spleen and bone marrow 
peripheral myeloid compartment. Yet, the molecular basis of this phenotype is yet to be 
determined. Future studies could focus on determination of the responsible molecule for 
increase of preGM in bone marrow and the spleen. Moreover, it would be advised to 
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determine impact of endothelial PHD2 loss on lineage committed progenitor activity in 
response to myeloid stress (e.g. upon increased LPS).  
 Similarly to the peripheral increase of the myeloid compartment, I observed a 
pronounced increase in the peripheral lymphocytes without significant changes in lymphoid 
progenitors in the bone marrow. However, lymphocytes are known to mature in secondary 
lymphatic organs (Camara et al. 2012). My analysis of B cell differentiation in secondary 
lymphoid organs revealed that altered hypoxic sensing in endothelial cells was detrimental 
for the development and maintenance of marginal zone B cells. This result supports studies 
showing that microenvironmental signaling is necessary for marginal zone B cell proper 
function (Girkontaite et al. 2001) (J.-H. Wang et al. 1998). Hypoxic preconditioning of mice 
does not lead to any changes in marginal zone B cell differentiation (Monson et al. 2014), 
and therefore it is likely that this change was induced through specific PHD2 alterations in 
endothelial cell signaling and not through local environmental changes. Although importance 
of cell-cell interactions during the marginal zone B cell development has been reported (J.-H. 
Wang et al. 1998), exact molecular mechanism responsible for developmental impairment of 
marginal zone B cells in KO mice remains unclear. A further analysis of these signaling 
changes is required to improve our understanding of the crucial endothelial cell signaling in 
support of marginal zone B cell differentiation. Positive outcome of this study could possibly 
aid in targeted therapy in diseases associated with marginal zone B cells.  
More importantly, B cells constitute only 20% of all lymphocytes found in the 
periphery. Therefore, the prominent lymphocyte increase comes entirely out of an increase of 
peripheral T cells. Further studies should focus on changes in T cell progenitors in the 
thymus and endothelial cell impact on their development. It is essential that we determine 
what mechanism is responsible for such profound effect, as well as how this affects 
functionality of the T cells.  
  
To determine changes in the endothelial cell functionality, I assessed endothelial cell 
recovery after myeloablation. Endothelial cells are crucial in hematopoietic cell recovery 
(Hooper et al. 2009). Specifically, it was shown that co-transplantation of HSCs and 
endothelial cells together improves HSC recovery after myeloablative injury as compared to 
transplantation of HSCs alone (Poulos et al. 2017; Chute et al. 2007).  
I first determined Flk1:cre-PHD2f/f KO endothelial cell recovery following non-lethal 
ionizing radiation. Low pericyte coverage has been associated with a decrease in vessel 
maturity and increased susceptibility to regression following radiation therapy (Bergers et al. 
2003). Flk1:cre-PHD2f/f KO mice had decreased levels of pericytes before and after 
irradiation. I did observe pronounce decrease in vessel number without a change of total 
vessel area. Similarly, I did not observe differences in prevalence of hypoxic areas. This 
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result underlines that the severity of induced damage was not influenced by loss of PHD2 on 
endothelial cells.  
Analysis of hematopoietic cell kinetics of recovery revealed a significant increase in 
WBC recovery in late stages (5-6 weeks) after myeloablation. This result indicates that I 
observed a return to the HSC homeostasis before irradiation, and not an improved recovery 
of bone marrow vasculature. In contrast, KO mice displayed improved hematopoietic 
recovery in the RBC compartment. All erythrocyte characteristics: red blood cell number, 
hemoglobin, and hematocrit were prominently elevated in KO mice in comparison to WT 
littermates within first three weeks post myeloablation.  
Recovery from acute anemia relies on stress erythropoiesis, a distinct pathway from 
normal red blood cell production (Socolovsky 2007). In contrast to previous studies, I did not 
observe any differences in splenic erythropoiesis, indicating that loss of PHD2 in the 
endothelial cells does not influence extramedullary hematopoiesis after stress induction. 
Therefore, I focused on bone marrow hematopoiesis.  
Hematopoietic stem cells can enter an emergency hematopoiesis pathway and 
circumvent the hierarchical differentiation ladder directly to erythroid progenitors (Singh et al. 
2018). Moreover, upon irradiation, HSC senescence increases while multipotent progenitors 
remained in cycle (Y. Wang et al. 2006). In contrast, with these studies I observed no 
changes in HSCs, but a selective tendency to senescence in both multipotent progenitors 
MPP3/4 and MPP2 in bone marrow. Similarly, I observed senescence of erythroid lineage 
committed precursors (preMegE). This result supports the notion that PHD2 inactivation from 
endothelial cells after myeloablation impacts actively proliferating progenitors but not HSCs 
during bone marrow restoration. However, because the observed differences are within 
weeks after the subjected radiation, I cannot rule out differences in the HSC frequency and 
activity shortly after assault. To test this alterative explanation will require analysis of 
hematopoietic compartment at earlier time points after hematopoietic transplantation.  
 
The observed faster recovery of the RBC compartment was most likely due to 
decreased RBC clearing in spleen, liver or bone marrow since I excluded possible alterations 
of facilitated RBC production. Erythroid precursors under stress conditions are capable of 
self-renewal in the spleen (Harandi et al. 2010). I showed that loss of PHD2 in endothelial 
cells led to a decrease in erythroblast precursors in bone marrow, with a simultaneous 
increased number of RBCs. Interestingly, another study determined that erythroid recovery is 
due to the increase in Epo levels acting on erythroblast precursors (Peslak et al. 2012). I 
showed that in my mouse model Epo levels are not altered, and therefore I conclude that 
facilitated recovery of RBC compartment is due to the direct influence of PHD2-related 
endothelial signaling. Moreover, Epo levels are also not responsible for the effect of 
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enhanced RBC survival in KO mice. These experiments illustrate that loss of PHD2 in 
endothelial cells results in effects on erythroid precursors in bone marrow. An important 
question left to determine is the altered clearing of the erythrocytes. Senescent or damaged 
RBCs require phagocytes and the humoral innate immune system (Boes et al. 2000; 
Ehrenstein et al. 2000). Spleen and liver have been shown to be associated with clearing of 
RBC (Cooper et al. n.d.). Perhaps future experiments could involve in detail analysis of red 
pulp macrophages in the spleen and the levels of RBC clearance. 
 
In order to explore the first steps of the downstream mechanism of the PHD2-induced 
phenotypes, I determined the responsible transcription factor. The data collected suggest a 
significant role for HIF-2α in bone marrow residing endothelial cells. In the double knockout 
Flk1:cre-PHD2f/fHIF2f/f that I generated, we rescued most of the hematopoietic phenotypes 
observed in the Flk1:cre-PHD2f/f mouse. These results support existing data showing that the 
HIF-2α transcription factor is responsible for hypoxia induced pulmonary hypertension (Dai et 
al. 2016; Cowburn et al. 2016; Kapitsinou et al. 2016). 
Changes in pulmonary arteries upon endothelial PHD2 loss are mediated specifically 
by HIF-2α induced signaling (Kapitsinou et al. 2016; Dai et al. 2016; S. Wang et al. 2017). 
Using mice with a double conditional knockout of PHD2 and HIF-2α, I was able to completely 
revert the observed changes in the white blood cell compartment and minimal decrease of 
platelet and red blood cells. Similarly, Flk1:cre-PHD2f/fHIF2f/f double knockout mice exposed 
to radiation did not reveal facilitated recovery of RBC/WBC. Remarkably, the double deficient 
mouse line only partially rescued vasodilation of bone marrow capillaries.  
 
In conclusion, I have shown that deficiency of PHD2 in endothelial cells influences 
bone marrow endothelial morphology. Moreover endothelial cells control multiple aspects of 
hematopoietic stem and progenitors cells, which upon PHD2 loss lead to profound changes 
in mature hematopoietic cells in the periphery during steady state and after myeloablation. 
Furthermore, I have shown that also the hematopoietic stem cell niche was greatly altered. 
Ultimately, I revealed that these effects were largely mediated through the downstream 
actions of the HIF-2α transcription factor. My work underscores the important role of oxygen 
sensor signaling in vivo and at the same time provides new insight into the interplay between 
endothelial cells and hematopoietic stem and progenitor cells.  
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HIF – hypoxia inducible factor 
VHL – von Hippel-Lindau 
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Sca1 – stem cell antigen-1 
cKit – tyrosine-protein kinase 
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EC – endothelial cells 
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8 Abstract 
	
	
	
	
Endothelial cells have an essential role in hematopoietic stem cell (HSC) regulation 
and maintenance during homeostasis and stress. Many cytokines and growth factors are 
required for normal HSC activity and are expressed by the endothelial cells. Along the 
support of hematopoietic stem cell activity, endothelial cells provide vessel delivery network 
to ensure proper oxygen delivery. Despite the importance of oxygen on endothelial cells, we 
lack the understanding of how oxygen sensing in endothelial cells regulates the local bone 
marrow niche cells and HSCs. To gain insight into this system, we developed a mouse model 
with an endothelial cell-specific knockout of the central oxygen sensor PHD2. Using this in 
vivo approach I sought to determine the impact of changes in hypoxia pathway proteins in 
endothelial cells on HSCs and their niche. 
First, I revealed that the morphology of bone marrow sinusoidal endothelial cells is 
altered upon loss of PHD2. I observed prominent vessel vasodilation accompanied by 
reduced hypoxic areas in their adjacent marrow. Moreover, I determined that inactivation of 
PHD2 in endothelial cells led to a decrease in bone volume and pericytes adjacent to 
endothelium. Remarkably, I observed profound differences in the hematopoietic cells of the 
periphery. Specifically, I observed a profound increase in circulating leukocytes of KO mice. 
This phenotype was related to an increase in hematopoietic stem and progenitor cells in 
bone marrow and spleen. Moreover, I found a complete impairment of B cell differentiation in 
the spleen, which consequently led to a profound decrease in marginal zone B cells. 
To assess the functionality of endothelial cells lacking PHD2, I subjected the mice to 
a non-lethal dose of ionizing radiation. Analysis of endothelial cell recovery in KO bone 
marrow revealed a decrease in the formation of new vessels without an impact on the overall 
vascular lumen compared to WT littermates. Similarly, I found an enhanced recovery of the 
RBC compartment during the first 3 weeks after irradiation in mice lacking PHD2 on 
endothelial cells. I excluded the possibility that this effect was due to an increased RBC 
production, which led to hypothesis that inhibition of endothelial PHD2 results in prolonged 
RBC survival or impaired RBC clearance. Additionally I observed an increase in quiescent 
hematopoietic progenitors cells in mice lacking PHD2 in endothelial cells that implies that 
endothelial PHD2 downstream signaling impact cycling of hematopoietic progenitors upon 
myeloablative stress.  
Finally, I demonstrated that a majority of the observed phenotypes in KO mice are 
mediated by the downstream HIF-2α transcription factor. Using my unique self-made double 
knockout mouse line simultaneously lacking PHD2 and HIF-2 in their endothelial cells, I was 
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able to reveal a reversal of the hematopoietic phenotypes observed in the single PHD2 
knockout mice during steady state. Additionally, the previously observed significant increase 
in lymphocyte and decrease in erythrocyte and thrombocyte numbers was genetically 
rescued in double knockout mice. Similarly, marginal zone B cell development returned to 
wild-type levels during steady state. Moreover, after subjecting mice to ionizing radiation I did 
not observe any significant differences between WT and KO in their hematopoietic cell 
recovery. 
Taken together, during my thesis I was able to demonstrate novel properties of 
hypoxia pathway proteins in endothelial cells having an impact on hematopoietic stem and 
progenitor cells as well as different compartments of their niche; both during steady state and 
radiation stress. In conclusion, my work underscores the critical importance of oxygen sensor 
signaling in the bone/bone marrow, and provides new insight into the interplay between the 
bone marrow endothelium and the hematopoietic system.   
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9 Zussamenfassung 
	
	
Endothelzellen spielen sowohl in Homöostase als auch in Stresssituationen eine 
wesentliche Rolle bei der Regulation und der Erhaltung der hämatopoetischen Stammzellen 
(HSC). Viele Zytokine und Wachstumsfaktoren werden für die natürliche HSC-Aktivität 
benötigt und von den Endothelzellen exprimiert. Neben der Unterstützung der 
hämatopoetischen Stammzellaktivität stellen Endothelzellen ein Gefäßversorgungsnetzwerk 
zur Verfügung, um eine ausreichende Sauerstoffversorgung zu gewährleisten. Trotz des 
Wissens um die Bedeutung von Sauerstoff für die Endothelzellen fehlt uns das Verständnis 
dafür, wie die Sauerstoffsensorik der Endothelzellen die lokalen Knochenmark-Nischenzellen 
und die HSCs reguliert. Um einen Einblick in diesen Mechanismus zu erhalten, haben wir ein 
Mausmodell mit einem endothelzellenspezifischen Knockout des zentralen 
Sauerstoffsensors PHD2 entwickelt. Mit diesem in vivo-Ansatz habe ich versucht, den 
Einfluss von Veränderungen der Hypoxie-Signalwegproteine in Endothelzellen auf HSCs und 
ihre Nische zu untersuchen.  
Ich konnte in der vorliegenden Arbeit zeigen, dass die Morphologie der sinusförmigen 
Endothelzellen des Knochenmarks nach Verlust von PHD2 verändert ist. Außerdem konnte 
ich eine ausgeprägte Gefäßvasodilatation, begleitet von reduzierten hypoxischen Bereichen 
im angrenzenden Knochenmark beobachten.  Zudem stellte ich fest, dass die Inaktivierung 
von PHD2 in Endothelzellen zu einem Rückgang des Knochenvolumens und zu einer 
Verminderung der an das Endothel angrenzenden Perizyten führt. Auffallend ist, dass sich 
gravierende Unterschiede in den hämatopoetischen Zellen der Peripherie zeigten, 
insbesondere war ein deutlicher Anstieg der zirkulierenden Leukozyten bei den KO-Mäusen 
zu erkennen. Dieser Phänotyp ist mit einer Vermehrung der hämatopoetischen Stamm- und 
Vorläuferzellen in Knochenmark und Milz verbunden. Darüber hinaus konnte ich zeigen dass 
die B-Zelldifferenzierung in der Milz vollständig zum Erliegen kommt, was zu einem 
signifikanten Rückgang der B-Zellen in der Marginalzone führt. 
Um die Funktionalität von Endothelzellen mit deletiertem PHD2 zu beurteilen, habe ich 
die Mäuse mit einer nicht-tödlichen Dosis ionisierender Strahlung behandelt. Die Analyse der 
endothelialen Zellregeneration im KO-Knochenmark zeigte eine Verminderung der 
Gefäßneubildung ohne Einfluss auf das gesamte Gefäßlumen im Vergleich zu 
unbehandelten Wurfgeschwistern. Außerdem stellte ich fest, dass sich in den ersten 3 
Wochen nach der Bestrahlung bei Mäusen mit fehlendem PHD2 auf der 
Endothelzellenoberfläche das RBC-Kompartiments schneller regeneriert. Ich konnte 
ausschließen, dass dieser Effekt auf eine erhöhte Produktion  von RBCs zurückzuführen ist, 
was zu der Hypothese führte, dass eine Verminderung des endothelialen PHD2 entweder zu 
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einem längerfristigen Überleben der RBCs oder zu einer beeinträchtigten RBC-Clearance 
führt. Zusätzlich habe ich einen Anstieg in der Anzahl der quieszenten hämatopoetischen 
Vorläuferzellen bei Mäusen mit endothelialer PHD2-Deletion beobachtet, was darauf 
hindeutet, dass das endotheliale PHD2 Downstream-Signaling den Zellzyklus von 
hämatopoetischen Vorläuferzellen bei myeloablativen Stress beeinflusst. 
Abschließend konnte ich zeigen, dass ein Großteil der beobachteten Phänotypen bei 
KO-Mäusen durch den nachgeschalteten Transkriptionsfaktor HIF-2α vermittelt wird. Die 
Verwendung meiner selbstgenerierten Doppel-Knockout-Mauslinie, bei der erstmalig 
gleichzeitig PHD2 und HIF-2 in den Endothelzellen deletiert sind, führte zu eine vollständige 
Umkehrung des hämatopoetischen Phänotyps der bei den PHD2-Knockout-Mäusen im 
Steady-State beobachtet wurde. Zusätzlich wird der zuvor beobachtete signifikante Anstieg 
der Lymphozyten und der Rückgang der Erythrozyten- und Thrombozytenzahl in den 
Doppel-Knockout-Mäusen genetisch wiederhergestellt. Gleichzeitig reduziert sich die 
Entwicklung der marginalen B-Zellen im stationären Zustand wieder auf das Wildtyp-Niveau. 
Des Weiteren habe ich nach der Bestrahlung von Mäusen mit ionisierender Strahlung keine 
signifikanten Unterschiede zwischen WT und KO in ihrer hämatopoetischen Zellregeneration 
mehr feststellen können. 
Zusammengenommen konnte ich in meiner Dissertation neue Eigenschaften von 
Hypoxie-Pathway-Proteinen in Endothelzellen mit Einfluss auf hämatopoetische Stamm- und 
Vorläuferzellen sowie auf verschiedene Kompartimente ihrer Nische demonstrieren; sowohl 
im stationären Zustand als auch nach Belastung durch Bestrahlung. Abschließend 
unterstreicht meine Arbeit die entscheidende Bedeutung der Sauerstoffsensorik im 
Knochenmark und gibt neue Einblicke in das Zusammenspiel zwischen dem Knochenmark-
Endothel und dem hämatopoetischen System.    
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